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Distinct DNA Damage Signaling in the Brain Distinguishes ATLD, NBS, and ATRSeckel Syndrome
Abstract
DNA double strand breaks create a situation of extreme stress under which a cell must either be capable
of repairing the lesions in order to continue replication or succumb to death. Not surprisingly, deficiencies
in DNA repair genes often lead to human diseases frequently associated with genomic instability, cancer
proneness, and neuropathology. Neurological consequences of aberrant DNA repair mechanisms vary
depending upon the affected gene and the pathway in which it operates. Ataxia-telangiectasia (A-T) is the
prototypical disease associated with DNA double strand break (DSB) repair deficiency and is
characterized by severe neural pathology. A-T results from homozygous mutations that inactivate the
ataxia-telangiectasia mutated (ATM) gene, and typically presents in early childhood as cerebellar ataxia
accompanied by ocular telangiectasias, elevated α-fetoprotein levels, and lymphoma predisposition
compounded by radiosensitivity. The ATM protein is a large (~380 kDa) protein kinase within the PI3K
family, which mediates cell cycle checkpoint activity and induces apoptosis through phosphorylation of
copious substrates. It is thought to be through apoptotic induction of newly post-mitotic cells harboring
lethal levels of DNA damage that Atm maintains integrity of the CNS, as it prevents incorporation of
genomically compromised neurons into the mature nervous system. Hypomorphic mutations in the
Mre11/Rad50/NBS1 complex (MRN complex), which is required for efficient ATM activity, result in distinct
syndromes. Ataxia-telangiectasia-like disease (ATLD) results from truncating mutations in Mre11 and
presents with neurodegeneration similar to that observed in A-T, but with longer latency and less severity.
Mutations in the FHA and BRCT domains of NBS1 result in Nijmegen Breakage Syndrome (NBS), which is
characterized by microcephaly without evidence of neurodegeneration. Thus far mutations in Rad50 have
not been reported in humans. In order to better understand the roles of ATM and MRN signaling in
maintaining physical and functional integrity of the CNS, mutant mice either null for Atm or carrying
hypomorphic mutations in Mre11 or Nbs1 were subjected to either endogenous or exogenous forms of
DNA damage and the signaling response was assessed in the brain. To understand the contrasting
neuropathology resulting from Mre11 or Nbs1 hypomorphic mutations, we analyzed neural tissue from
Mre11ATLD1/ATLD1 and Nbs1DB/DB mice after genotoxic stress. We found a pronounced resistance to
DNA damage-induced apoptosis after ionizing radiation or DNA ligase IV (Lig4) loss in the Mre11ATLD1/
ATLD1 nervous system that was associated with defective Atm activation and phosphorylation of its
substrate p53. Apoptosis occurred normally in the Nbs1ΔB/ΔB brain. We also conditionally disrupted Lig4
throughout the nervous system using Nestin-cre (Lig4Nes-Cre), and while viable, these mice showed
pronounced microcephaly and a prominent age-related accumulation of DNA damage throughout the
brain. Either Atm-/- or Mre11ATLD1/ATLD1 genetic backgrounds, but not Nbs1ΔB/ΔB rescued Lig4NesCre microcephaly. Thus, DNA damage signaling in the nervous system is different between ATLD and
NBS, and likely explains their respective neuropathology. Ataxia-telangiectasia and Rad3-related (ATR) is a
large serine/threonine kinase that is highly similar in structure to ATM and phosphorylates many
overlapping substrates. Hypomorphic mutations in ATR have been associated with some cases of Seckel
syndrome, a microcephalic condition. Despite the similarities between ATM and ATR, inactivation of either
kinase has quite distinct consequences. Unlike ATM, ATR is essential for embryonic development, as Atr/- embryos are lethal by E7.5. To better understand the differing roles of ATM and ATR in the nervous
system, a conditional Atr mutant was crossed onto the Nestin-cre transgenic line. AtrloxP/loxP; Nestin-cre
( AtrNes-cre) animals displayed early post-natal lethality and severe neurogenesis defects, particularly
striking in the cerebellum due to decreased proliferation and viability of granule neuron progenitors.
Surprisingly, progenitors in the rhombic lip were largely unaffected in AtrNes-cre embryos whereas the
granule cell precursors of the cerebellar external germinal layer (EGL) displayed DNA damage as early as
E13.5 and p53-dependant apoptosis by E15.5. Between E15.5 and E16.5 p53 independent cell cycle arrest
was inferred by decreased proliferation of the remaining granule cell precursors in the EGL. DNA damage

was not observed in the rhombic lip until E16.5. The forebrain showed a similar pattern of acquired
damage followed by apoptosis and decreased proliferation. The p53-null genetic background did not
substantially rescue the AtrNes-cre phenotype despite blocking apoptosis. This data indicates that
proliferation arrest is the major factor causing ATR-Seckel syndrome and that ATR does not significantly
contribute to p53-induced apoptosis in proliferating neural progenitors. AtrNes-cre animals were crossed
onto an Atm conditional background (AtmNes-cre) in order to assess how ATM and ATR cooperate in
maintaining homeostasis in the brain. The AtmNes-cre background failed to alter the AtrNes-cre
phenotype, underscoring the divergence of ATR and ATM function during embryogenesis, despite
overlapping substrates between the kinases. In summary, this work provides us with important insight
into the requirements for specific DNA damage signaling molecules in the nervous system. ATM and ATR
appear to have distinct roles in the nervous system with ATM required for elimination of compromised
early post-mitotic neurons, while ATR is critical for maintaining integrity and replicative capacity of
progenitor populations. Based upon this study, there is no obvious cross-talk or overlap between Atm and
Atr signaling in the nervous system as each plays a separate role in different cell populations.
Furthermore, we have begun to tease out the existence of independent signaling roles between Mre11
and Nbs1 in regard to Atm activity. While Mre11 mutations associated with ATLD compromise Atmdependant apoptosis, Nbs1 hypomorphism linked to NBS does not appear to negatively impact upon
known Atm function in the nervous system. Overall these data provide new insights into the specific
genetic requirements for DNA double strand break repair in the nervous system.
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ABSTRACT
DNA double strand breaks create a situation of extreme stress under which a cell
must either be capable of repairing the lesions in order to continue replication or succumb
to death. Not surprisingly, deficiencies in DNA repair genes often lead to human diseases
frequently associated with genomic instability, cancer proneness, and neuropathology.
Neurological consequences of aberrant DNA repair mechanisms vary depending upon the
affected gene and the pathway in which it operates. Ataxia-telangiectasia (A-T) is the
prototypical disease associated with DNA double strand break (DSB) repair deficiency
and is characterized by severe neural pathology. A-T results from homozygous mutations
that inactivate the ataxia-telangiectasia mutated (ATM) gene, and typically presents in
early childhood as cerebellar ataxia accompanied by ocular telangiectasias, elevated !fetoprotein levels, and lymphoma predisposition compounded by radiosensitivity. The
ATM protein is a large (~380 kDa) protein kinase within the PI3K family, which
mediates cell cycle checkpoint activity and induces apoptosis through phosphorylation of
copious substrates. It is thought to be through apoptotic induction of newly post-mitotic
cells harboring lethal levels of DNA damage that Atm maintains integrity of the CNS, as
it prevents incorporation of genomically compromised neurons into the mature nervous
system. Hypomorphic mutations in the Mre11/Rad50/NBS1 complex (MRN complex),
which is required for efficient ATM activity, result in distinct syndromes. Ataxiatelangiectasia-like disease (ATLD) results from truncating mutations in Mre11 and
presents with neurodegeneration similar to that observed in A-T, but with longer latency
and less severity. Mutations in the FHA and BRCT domains of NBS1 result in Nijmegen
Breakage Syndrome (NBS), which is characterized by microcephaly without evidence of
neurodegeneration. Thus far mutations in Rad50 have not been reported in humans.
In order to better understand the roles of ATM and MRN signaling in maintaining
physical and functional integrity of the CNS, mutant mice either null for Atm or carrying
hypomorphic mutations in Mre11 or Nbs1 were subjected to either endogenous or
exogenous forms of DNA damage and the signaling response was assessed in the brain.
To understand the contrasting neuropathology resulting from Mre11 or Nbs1
hypomorphic mutations, we analyzed neural tissue from Mre11ATLD1/ATLD1 and Nbs1!B/!B
mice after genotoxic stress. We found a pronounced resistance to DNA damage-induced
apoptosis after ionizing radiation or DNA ligase IV (Lig4) loss in the Mre11ATLD1/ATLD1
nervous system that was associated with defective Atm activation and phosphorylation of
its substrate p53. Apoptosis occurred normally in the Nbs1!B/!B brain. We also
conditionally disrupted Lig4 throughout the nervous system using Nestin-cre (Lig4Nes-Cre),
and while viable, these mice showed pronounced microcephaly and a prominent agerelated accumulation of DNA damage throughout the brain. Either Atm-/- or
Mre11ATLD1/ATLD1 genetic backgrounds, but not Nbs1!B/!B rescued Lig4Nes-Cre
microcephaly. Thus, DNA damage signaling in the nervous system is different between
ATLD and NBS, and likely explains their respective neuropathology.
Ataxia-telangiectasia and Rad3-related (ATR) is a large serine/threonine kinase
that is highly similar in structure to ATM and phosphorylates many overlapping
v

substrates. Hypomorphic mutations in ATR have been associated with some cases of
Seckel syndrome, a microcephalic condition. Despite the similarities between ATM and
ATR, inactivation of either kinase has quite distinct consequences. Unlike ATM, ATR is
essential for embryonic development, as Atr-/- embryos are lethal by E7.5. To better
understand the differing roles of ATM and ATR in the nervous system, a conditional Atr
mutant was crossed onto the Nestin-cre transgenic line. AtrloxP/loxP; Nestin-cre ( AtrNes-cre)
animals displayed early post-natal lethality and severe neurogenesis defects, particularly
striking in the cerebellum due to decreased proliferation and viability of granule neuron
progenitors. Surprisingly, progenitors in the rhombic lip were largely unaffected in AtrNescre
embryos whereas the granule cell precursors of the cerebellar external germinal layer
(EGL) displayed DNA damage as early as E13.5 and p53-dependant apoptosis by E15.5.
Between E15.5 and E16.5 p53 independent cell cycle arrest was inferred by decreased
proliferation of the remaining granule cell precursors in the EGL. DNA damage was not
observed in the rhombic lip until E16.5. The forebrain showed a similar pattern of
acquired damage followed by apoptosis and decreased proliferation. The p53-null genetic
background did not substantially rescue the AtrNes-cre phenotype despite blocking
apoptosis. This data indicates that proliferation arrest is the major factor causing ATRSeckel syndrome and that ATR does not significantly contribute to p53-induced
apoptosis in proliferating neural progenitors. AtrNes-cre animals were crossed onto an Atm
conditional background (AtmNes-cre) in order to assess how ATM and ATR cooperate in
maintaining homeostasis in the brain. The AtmNes-cre background failed to alter the AtrNescre
phenotype, underscoring the divergence of ATR and ATM function during
embryogenesis, despite overlapping substrates between the kinases.
In summary, this work provides us with important insight into the requirements
for specific DNA damage signaling molecules in the nervous system. ATM and ATR
appear to have distinct roles in the nervous system with ATM required for elimination of
compromised early post-mitotic neurons, while ATR is critical for maintaining integrity
and replicative capacity of progenitor populations. Based upon this study, there is no
obvious cross-talk or overlap between Atm and Atr signaling in the nervous system as
each plays a separate role in different cell populations. Furthermore, we have begun to
tease out the existence of independent signaling roles between Mre11 and Nbs1 in regard
to Atm activity. While Mre11 mutations associated with ATLD compromise Atmdependant apoptosis, Nbs1 hypomorphism linked to NBS does not appear to negatively
impact upon known Atm function in the nervous system. Overall these data provide new
insights into the specific genetic requirements for DNA double strand break repair in the
nervous system.
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CHAPTER 1

INTRODUCTION!

1.1 DNA Double Strand Break Repair
DNA double strand breaks (DSBs) are considered the most deleterious form of
DNA damage. When left unrepaired, DSBs can cause apoptosis or the accumulation of
genomic instability. DNA damage initiates complex signaling cascades that result in cell
cycle checkpoint activation, DNA repair or apoptosis. Much of our understanding of
these pathways comes from studies using patient-derived cell lines or mutant mice
designed to model DNA repair deficits (Friedberg & Meira, 2006; Rosenthal & Brown,
2007). ATM and ATR sit at the apex of DNA double strand break signaling, and are
responsible for phosphorylating multiple substrates that impact cellular fate after damage.
While ATM is predominantly activated by DSBs such as those produced by irradiation
and subsequently initiates cell cycle checkpoints and/or apoptosis, ATR responds to
agents that interfere with DNA replication (i.e., UV irradiation and hydroxyurea) and is
essential to cellular viability (Brown & Baltimore, 2000; Cimprich & Cortez, 2008;
Hurley & Bunz, 2007). The precise recruitment order of DNA damage signaling
molecules to DSB sites is unclear, as the rapidity with which the damage response is
activated makes delineating what comes first challenging. Phosphorylation of H2AX on
the C-terminus Ser 139 is one of the earliest events occurring in response to DNA
damage, and can be visualized immunohistochemically as distinct nuclear foci that mark
DNA DSBs. A major function of "-H2AX is recruitment of other DNA damage response
factors to the sites of DNA DSBs (Fernandez-Capetillo et al., 2004; Sedelnikova et al.,
2003). Though H2AX is not essential in the mouse, its loss predisposes to genomic
instability (Celeste et al., 2003; Celeste et al., 2002). H2AX phosphorylation facilitates
recruitment of MDC1 to the DNA break via binding to the "-H2AX C-terminus
(Goldberg et al., 2003; Lou et al., 2003; Stewart et al., 2003). This interaction is required
for signal amplification and effective modulation of downstream signaling (BekkerJensen et al., 2005; Lou et al., 2006; Stucki et al., 2005; Stucki & Jackson, 2006).
Two predominant pathways of DSB repair have been identified, nonhomologous
end-joining (NHEJ) and homologous recombination (HR). These pathways are
differentially required depending upon developmental stages and tissue type. A
distinguishing characteristic between the DNA DSB pathways is the requirement of HR
for a sister chromatid present in the S/G2 phase of the cell cycle. This implies that the
repair of DSBs in non-replicating cells will occur via NHEJ, and it has been shown in the
developing murine nervous system that abrogation of HR results in Atm-independent
apoptosis in proliferating regions whereas loss of NHEJ repair leads to Atm-dependant
apoptosis in post-mitotic areas (Gao et al., 2000; Lee et al., 2000; Orii et al., 2006). HR is
an error-free process that uses a sister chromatid as template DNA to achieve precise
repair (Helleday et al., 2007; Thacker & Zdzienicka, 2004; West, 2003). Homology* Adapted by permission from Phillips ER and McKinnon PJ (2007). Oncogene, 26,
7799-808.
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directed repair initially involves an Mre11-Rad50-Nbs1 (MRN)-mediated 5’-3’ resection
followed by Rad51-mediated homology search and strand invasion. The Rad51
recombinase complex functions in concert with a series of other factors including the
Rad51 paralogs (Xrcc2, Xrcc3, RAD51L1, RAD51L2, RAD51L3), Rad52, and Rad54
proteins during which the processed DNA strand invades the sister chromatid and
initiates recombination (Helleday et al., 2007; Heyer et al., 2006; Thacker and
Zdzienicka, 2004; West, 2003; Wyman et al., 2004). Strand invasion and migration
involves formation of a structure termed a Holliday Junction, which is resolved via
Rad54, Mus81/Emc1 and Rad51C/Xrcc3 following repair synthesis by DNA polymerase,
thus completing the repair process. As would be surmised from the essential importance
of homologous recombination during embryonic development, studies in the mouse
indicate that many of the above factors are essential for survival and their inactivation
leads to lethality (Friedberg & Meira, 2006).
In contrast to HR, NHEJ is an error-prone mechanism that involves the DNAdependent protein kinase (DNA-PK) and the DNA ligaseIV (Lig4)-Xrcc4 complex that
together facilitate re-joining of broken non-compatible DNA ends (Lieber et al., 2003).
The DNA-PK complex contains the Ku70 and Ku80 proteins, which recognize the break
and mediate recruitment of the DNA-PK catalytic subunit (DNA-PKcs) a
serine/threonine kinase whose autophosphorylation and phosphorylation of other factors
including H2AX is required for efficient NHEJ (Bassing & Alt, 2004; Burma & Chen,
2004; Lees-Miller & Meek, 2003). Ligation of the DNA ends occurs via Lig4 in
conjunction with its binding partner Xrcc4. An additional factor, Cernunnos/XLF, has
been identified as a binding partner of the Lig4-Xrcc4 complex and appears to be
necessary for efficient ligation via NHEJ (Ahnesorg et al., 2006; Buck et al., 2006).
Subsets of NHEJ may involve other factors such as Artemis (Jeggo & O'Neill, 2002;
Moshous et al., 2001). The extent to which Artemis is required during canonical NHEJ
(independent of V(D)J recombination) remains uncertain, as conflicting data on its
requirement for end-joining have been reported (Riballo et al., 2004; Rooney et al., 2003;
Wang et al., 2005c; Zhang et al., 2004). However, DNA Ligase IV (Lig4) and Xrcc4 are
essential for NHEJ and embryonic survival (Barnes et al., 1998; Frank et al., 1998; Gao
et al., 1998), and their interaction is required for efficient end-joining as Lig4 alone is not
sufficient to complete repair in the absence of Xrcc4 (Bassing & Alt, 2004; Critchlow et
al., 1997; Grawunder et al., 1997; Grawunder et al., 1998a; Grawunder et al., 1998b).
While HR is available for repair during late S phase, NHEJ is most prominently activated
in G1, G0, and early S phase of the cell cycle (Rothkamm et al., 2003; Thacker &
Zdzienicka, 2004). However, animal studies indicate that there is cooperativity between
these pathways during development (Couedel et al., 2004; Mills et al., 2004).
While NHEJ requires DNA-PK and Lig4-Xrcc4, studies suggest that there may be
an NHEJ repair pathway that utilizes other components, and in some cases can occur
without DNA-PK (DiBiase et al., 2000; Perrault et al., 2004). For instance DNA ligase III
(Lig3) has been implicated as an alternate ligase that may function in NHEJ (Wang et al.,
2005; Windhofer et al., 2007). In vitro evidence implicating PARP-1 and Xrcc1/Lig3 in
NHEJ has also been obtained through end-joining assays (Audebert et al., 2004). The
physiologic relevance of such phenomena remains unclear though, as no substantial
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compensatory mechanisms appear in either Xrcc4-deficient or Lig4-deficient mice. If
Lig3 does compensate in vivo, it does so only partially and is insufficient for normal
mammalian development in the absence of Lig4.
The requirement for efficient DNA repair mechanisms is underscored by the severe
consequences observed in individuals lacking full activity of signaling factors or repair
genes. Human deficiencies in ATM, ATR, MRN, or Lig4 (to list only a few) have been
identified and present with neuropathology, immunodeficiency, and chromosomal
instability. Though many characteristics of such genetic aberrations overlap, there are
also distinctions indicative of differing specific functions.

1.2

Consequence of DSB Repair Deficiencies in Humans
1.2.1 Ataxia-telangiectasia, mutated (ATM)

The canonical example of DNA DSB sensitivity in humans is the
neurodegenerative syndrome, ataxia-telangiectasia (A-T). This disease is characterized by
pronounced cerebellar ataxia attributed to Purkinje cell (PC) degeneration, ocular
telangiectasia, lymphoma, sterility, immunodeficiency, dysarthria and radiosensitivity
(Chun & Gatti, 2004; McKinnon, 2004). A-T results from null mutations in the gene
ATM (ataxia-telangiectasia, mutated) (Savitsky et al., 1995). ATM is a serine/threonine
kinase that modulates many substrates critical to the DNA damage response (Bakkenist &
Kastan, 2004; Shiloh, 2003; Shiloh, 2006). Tissue specificity is an important aspect of
ATM function, and relates to the pleiotropic nature of A-T. For instance, some ATM
deficient tissues are extremely radiosensitive such as the intestine or hematopoietic
system, while in contrast ATM-deficient immature neurons are radioresistant (Frappart &
McKinnon, 2006).
Activation of ATM in response to DNA damage involves autophosphorylation,
which converts ATM from an inactive dimer to an active monomer (Bakkenist & Kastan,
2003). ATM autophosphorylation sites have been identified on serines 1981, 1893 and
367. Transfection of A-T cells with cDNAs containing mutations of these sites results in
aberrant kinetics of p53 and Chk2 phosphorylation, suggesting each site contributes to
ATM activity (Bakkenist & Kastan, 2003; Kozlov et al., 2006). However, the in vivo
significance of such events remains unclear. Transgenic mice expressing an S1987A
mutated BAC were crossed onto an Atm-/- background and found to be indistinguishable
from Atm+/- mice, as growth retardation, genomic instability, lymphocyte development,
and ATM-dependent phosphorylation of Chk2, SMC1, and p53 were restored in
AtmTgS1987AAtm-/- mice (Pellegrini et al., 2006). A transgenic mouse model in which all
three currently known autophosphorylation sites were inactivated was recently reported.
Atm-dependent DNA damage responses were normal in these mice. Thus, while
phosphorylation of these sites is indicative of ATM activation, they do not appear to be
required for ATM signaling itself (Daniel et al., 2008).
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An important issue is precisely how DNA DSBs signal to ATM. This occurs via
the MRN complex. MRN-deficient cells show abrogated ATM autophosphorylation and
impaired phosphorylation of p53, Chk2, and Smc1 concomitant with suppression of the
ATM-dependent G2/M checkpoint (Carson et al., 2003; Difilippantonio et al., 2005;
Uziel et al., 2003). These studies implicate the MRN complex as the primary sensor of
DNA damage and place it upstream of ATM activation. Mechanistically, MRNdependent ATM activation at DNA breaks has been reported to require interaction
between ATM HEAT repeats and the C-terminal FXF/Y domain of Nbs1 (Falck et al.,
2005; You et al., 2005). The in vivo significance of this requires further study as while
the NBS1 C-terminal mutant mice show apoptotic defects in the thymus, ATM functions
were at least partially intact suggesting that interaction with the NBS1 C-terminus is
dispensable for most ATM activity (Difilippantonio et al., 2007; Stracker et al., 2007).
In response to DNA damage, ATM phosphorylates p53 on serine 15 and other
sites thereby directly mediating its activation and stabilization (Lavin & Kozlov, 2007;
Lukas et al., 2004). ATM-dependent phosphorylation activates Chk2, which blocks DNA
replication via enhanced p53 activation and Cdc25A degradation (Falck et al., 2002).
ATM indirectly affects p53 stabilization through down-regulation of its ubiquitin ligase
Mdm2 (Khosravi et al., 1999; Maya et al., 2001). COP1 is yet another E3 ligase of p53
that ATM phosphorylates, resulting in its degradation and subsequent p53 stabilization
(Dornan et al., 2006). These ATM-dependent modifications collectively function to affect
p53-dependent cell cycle arrest or apoptosis.
In addition to directly regulating cell cycle checkpoints, apoptosis, and DNA
repair, ATM has also been implicated in mediating DNA damage-induced chromatin
modification. Treatment of primary human fibroblasts with chromatin modifying agents
(chloroquine or HDAC inhibitors) induced ATM activation without forming obvious
DNA DSBs, suggesting that direct DNA damage is not the only activator of ATM
signaling (Bakkenist & Kastan, 2003). Identification of ATM-dependent, DNA damageinduced chromatin relaxation via KAP-1 activity has further demonstrated the
dependence of DNA repair on alteration of chromatin structure. ATM phosphorylates
KAP-1 on Ser 824, and ablation of this site was demonstrated to abolish DSB-induced
chromatin relaxation and resulted in cellular hypersensitivity to DSB-inducing agents
(Ziv et al., 2006). Moreover, ATM has also been implicated in regulating ordered
chromatin changes after DNA breaks to facilitate DNA repair (Berkovich et al., 2007). In
essence ATM targets a vast array of substrates, which likely account for the pleiotropic
nature of A-T.

1.2.2 Ataxia-telangiectasia and Rad3-related (ATR)
Mutations in the other major DNA repair kinase, ataxia-telangiectasia and Rad3
related (ATR), have been attributed to the microcephalic condition Seckel syndrome.
While ATM responds to DSBs (such as induced by IR) through Chk2 activation, ATR
targets Chk1 in response to DNA replication stress, and activates the intra-S phase
checkpoint (Conti et al., 2007). Seckel syndrome is inherited autosomal recessively and
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characterized by microcephaly, intrauterine growth defects, dwarfism, and mild mental
retardation (OMIM #210600). In some affected individuals, hypomorphic splicing
mutations in ATR have been identified as the disease causation (O'Driscoll et al., 2004;
O'Driscoll et al., 2003a; O'Driscoll et al., 2003b). While there is reported cross-talk
between ATM and ATR (Jazayeri et al., 2006; Matsuoka et al., 2007; Yoo et al., 2007),
they have separable biochemical roles and complete ATR loss is incompatible with
viability. Atr-/- embryos die between the blastocyst stage and E7.5. Isolation of Atr-/embryos at day 3.5 revealed that blastocysts hatched normally from the zona pellucida
and implanted onto tissue culture plastic after 1 day in culture, but failed to expand
beyond 2 days in culture and died by culture day 4 due to accumulation of caspase 3independent DNA fragmentation and consequent apoptosis (Brown & Baltimore, 2000).
Despite structural similarity and overlapping substrates between ATR and ATM, there is
unlikely to be significant redundancy in their roles during neurogenesis. Other
microcephalic diseases associated with DSBR deficiency include LIG4 syndrome,
Nijmegen breakage syndrome, and possibly primary microcephaly due to the recently
described microcephalin gene (MCPH).

1.2.3 DNA ligase IV (Lig4)
Human deficiency in DNA ligase IV causes microcephaly, developmental delay,
radiosensitivity and immunodeficiency (O'Driscoll et al., 2001). LIG4 syndrome was first
identified in a radiosensitive leukemia patient carrying a missense mutation (R278H) that
conferred decreased ligation capacity (Riballo et al., 1999). This mutation was
subsequently shown to decrease LIG4 adenylation and ligation activity by about 10%
(O'Driscoll et al., 2001; Riballo et al., 1999; Riballo et al., 2001). Additional LIG4
syndrome individuals have since been identified with variable phenotypic penetrance
dependant upon the particular hypomorphic mutations expressed. For instance, an
individual with an R278H mutation in addition to the N-terminal polymorphisms A3V
and T9I presented with microcephaly, pancytopenia, and developmental delay (Girard et
al., 2004; O'Driscoll et al., 2001). In vitro studies revealed no residual LIG4 adenylation
or ligation activity in the 411BR mutation (Girard et al., 2004). Two siblings who
presented with SCID, growth defects, and microcephaly were found to have compound
heterozygous mutations conferring a Q280R substitution on one allele and a K424 frameshift mutation, resulting in truncation of the C-terminus on the other allele (Buck et al.,
2006b). Given the lethality of mice with inactivated Lig4 the hypomorphic mutations
present in the human syndrome suggests that loss of LIG4 would not be compatible with
viability, and that even attenuated activity has a substantial developmental effect.

1.2.4 The Mre11/Rad50/Nbs1 complex (MRN)
While no human deficiency has been reported for Rad50, hypomorphic mutations
in Mre11 and Nbs1 cause ataxia-telangiectasia like disease (ATLD) and Nijmegen
breakage syndrome (NBS), respectively (Stewart et al., 1999; Varon et al., 1998). ATLD
presents with cerebellar ataxia similar that seen in A-T, but less severe and with a longer
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latency, whereas NBS is characterized by microcephaly without neurodegeneration.
Overlapping features of ATLD, A-T, and NBS include immunodeficiency, chromosomal
instability, and reproductive defects (Pitts et al., 2001; Stewart et al., 1999; Varon et al.,
1998). Given the differing neurologic phenotypes of A-T, ATLD, and NBS, despite
overlapping features outside the brain, it is reasonable to suspect that there is tissuespecificity to Nbs1 function. Figure 1.1 summarizes the relationships between A-T,
ATLD, NBS, ATR-SS, and LIG4 syndrome.

1.2.5 Mouse models of DNA repair deficiencies
Atm null mice have provided much insight into the nature of A-T by
recapitulating many features of the disease, including growth retardation,
immunodeficiency, sterility, and thymic lymphoma. However, no overt
neurodegeneration has been observed in Atm-/- mice, thus impeding comprehension of
how and why cerebellar degeneration occurs in A-T individuals (Barlow et al., 1996a;
Elson et al., 1996b; Herzog et al., 1998; Xu et al., 1996a). Human A-T derived cell lines
and mouse Atm-null cells display similar phenotypes including premature senescence,
radiation sensitivity, decreased p53 induction and cell cycle checkpoint defects (Barlow
et al., 1996a; Xu & Baltimore, 1996; Xu et al., 1998).
Irradiation studies in the developing Atm-null NS showed that ATM regulates
p53-dependent apoptosis of newly post-mitotic neurons, implying that it functions as a
clearance mechanism of irreparably damaged cells during development. Post-mitotic
neurons of the developing CNS and the dorsal root ganglia of postnatal Atm-/- mice were
resistant to irradiation-induced apoptosis in comparison to wild-type animals. Consistent
with the lack of apoptosis, p53 stabilization was drastically attenuated in the
radioresistant Atm-/- tissues and there was a similar lack of IR-induced neural apoptosis in
p53-null animals (Chong et al., 2000; Herzog et al., 1998; Lee et al., 2001). Chk2, Puma,
and Bax deficiencies have also been shown to abrogate IR-induced apoptosis in the
developing nervous system (Chong et al., 2000; Jeffers et al., 2003; Takai et al., 2002).
The Mre11ATLD1/ATLD1 mouse model harboring a hypomorphic mutation designed
to mimic mutations found in ATLD patients showed chromosomal instability and
checkpoint defects in primary cell cultures, and Mre11ATLD1/ATLD1 females failed to
produce offspring due to reduced embryonic viability (Theunissen et al., 2003). Likewise,
the nibrin hypomorph Nbs1"B/"B mouse model did not recapitulate microcephaly as seen
in NBS individuals, but did show a cellular phenotype identical to that of primary
cultures derived from NBS patients including intra-S phase checkpoint defects,
chromosomal instability, and radiosensitivity (Williams et al., 2002). Additionally, the
NBS1m/m mouse model displayed lymphoma predisposition and infertility, as did the
humanized mouse model hNbs1657"5 (Difilippantonio et al., 2005; Kang et al., 2002).
Further understanding of NBS neuropathology came with the conditional Nbs1 knockout
model, Nbnf6/f6. On a Nestin-cre background, this mouse model demonstrated
microcephaly and severe developmental defects of the cerebellum, associated with
decreased proliferation of granule cell progenitors and increased apoptosis of inner
6

Figure 1.1 Diseases associated with DNA double-strand break repair deficits.
Ataxia-telangiectasia mutated (ATM) deficiency results in a pleiotropic phenotype, the
most debilitating feature of which is progressive neurodegeneration. MRE11 mutations
are associated with A-T-like disease (ATLD), which mimics the neurodegenerative
aspect of A-T. Though NBS1 acts with MRE11 to regulate ATM activation, NBS1
hypomorphic mutations are associated with microcephaly, not neurodegeneration. The
Nijmegen breakage syndrome (NBS) phenotype overlaps with ATM and rad3-related
(ATR) deficiency more so than with A-T. Mutation of LIG4 is also associated with
microcephaly and resembles NBS and ATR-Seckel syndrome.
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external granule layer (EGL) cell populations (Frappart et al., 2005). While the Nbnf6/f6
model provides insight into how DNA repair deficiency can affect the developing
nervous system, the reason for reliance of the mature CNS upon ATM function remains
obscure. Rescue of Lig4-mediated apoptosis by Atm-deficiency demonstrated the
requirement for ATM-dependent apoptosis during neural development to maintain
genomic integrity of cells incorporated into the mature nervous system (Lee et al., 2000;
Sekiguchi et al., 2001). Accordingly, p53 deficiency rescued Xrcc4/Lig4-mediated
apoptosis as well (Frank et al., 2000). Interestingly, Lig4-/-p53-/- mice survived into
adulthood and developed pro-B cell lymphomas or medulloblastomas (Frank et al., 2000;
Lee & McKinnon, 2002), whereas Lig4-/-Atm-/- animals died perinatally (Lee et al., 2000;
Sekiguchi et al., 2001). These studies suggest that ATM deficiency allows cells carrying
a genotoxic level of DSBs to be incorporated into the nervous system, and eventually
such neurons would succumb to apoptosis or some other form of death resulting in
neurodegeneration (Lee & McKinnon, 2007). Furthermore, these studies indicate a
developmental role of ATM in addition to mediation of p53-dependent apoptosis that are
vital in responding to DNA damage. Table 1.1 summarizes relevant mouse models and
the degree to which their respective diseases are phenocopied.
The DNA DSB response is required for development and maintenance of tissue
homeostasis. The DNA damage response is also a barrier to transformation, and if
inactive in the face of replication stress, cellular transformation can occur (Bartkova et
al., 2005; Bartkova et al., 2006; Di Micco et al., 2006). Multiple human syndromes result
from the mutation of genes required for the response to DNA DSBs. In many cases these
syndromes feature defective developmental processes, including microcephaly,
neurodegeneration, immunodeficiency, and growth retardation. Delineating the
underlying molecular defects in these diseases promises to uncover further important
details about DNA DSB repair (Phillips & McKinnon, 2007).
The molecular mechanisms responsible for the distinct neuropathologies observed
in ATLD and NBS are of particular interest, as Mre11 and Nbs1 are both implicated in
ATM activation, coordination of the DSB response, and maintaining the integrity of
cellular proliferation during early mammalian development. The fact that hypomorphic
mutations in Mre11 cause neurodegeneration while Nbs1 mutations have been associated
with microcephaly suggests that different downstream signaling events occur in ATLD
and NBS. In Chapter 2 of this work, mouse models for ATLD and NBS were used to
evaluate the consequences of hypomorphic mutations in either Mre11 or Nbs1 in the
nervous system, as pertaining to DSB signaling. Similar to NBS, ATR-Seckel syndrome
is associated with developmental delay and microcephaly. ATM and ATR are very
similar kinases that mediate the DNA DSB response, but human deficits in these proteins
result in very different consequences. To better understand the relationship between ATM
and ATR signaling in the nervous system, a conditional Atr knock-out mouse model was
used to specifically evaluate how Atr functions in the nervous system to ensure
developmental integrity. Double conditional Atr, Atm mutant mice were generated to
assess how Atm and Atr cooperate in development and maintenance of the CNS. The
work presented in this dissertation has provided valuable new insights into the signaling
pathways that prevent neuropathology associated with DNA damage.
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Table 1.1 Phenotypes resulting from inactivation of murine DNA damage response
genes.
Gene

Mouse Model

Mouse Phenotype

ATM

Atm-/(Barlow et al.,
1996b; Elson et
al., 1996a; Xu et
al., 1996b)
NBS1m/m
(Kang et al.,
2002)

Thymoma
predisposition,
sterility,
radiosensitivity

NBS

Nbnf6/f6; nestinCre
(Frappart et al.,
2005)
NBS1-/(Zhu et al., 2001)
NBS1"B/"B
(Williams et al.,
2002)

MRE11

DNA
Ligase IV

ATR

hNbs1657"5
(Difilippantonio
et al., 2005)
Mre11ATLD1/ATLD1
(Theunissen et al.,
2003)
Lig4-/(Barnes et al.,
1998; Frank et al.,
1998)
Lig4Y288C
hypomorph
(Nijnik et al.,
2007)
Atr-/(Brown &
Baltimore, 2000)

Thymoma
predisposition,
sterility,
radiosensitivity
Microcephaly,
ataxia, cerebellar
development defects
Embryonic lethality
(~E7.5)
Cell cycle
checkpoint defect in
MEFs, synthetic
lethal with Atm-/Impaired
development,
lymphoma
Cell cycle
checkpoint defect in
MEFs, synthetic
lethal with Atm-/Embryonic lethality
(~E16.5), neuraxis
wide apoptosis,
immunodeficiency
Growth retardation,
immunodeficiency,
hematopoietic stem
cell deficiency
Embryonic lethality
(before E7.5)
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Human
Disease
Ataxiatelangiectasia

Nijmegen
breakage
syndrome

Human Phenotype
Cerebellar ataxia,
ocular telangiectasia,
thymoma, sterility,
genomic instability,
radiosensitivity
Microcephaly,
growth retardation,
immunodeficiency,
characteristic facial
features, lymphoma

Ataxiatelangiectasia
like disease

Cerebellar ataxia,
genomic instability

LIG4
syndrome

Microcephaly,
characteristic facial
features,
immunodeficiency,
radiosensitivity,
growth retardation

Seckel
syndrome

Microcephaly,
characteristic facial
features,
chromosomal
instability

CHAPTER 2 DIFFERENTIAL DNA DAMAGE
SIGNALING ACCOUNTS FOR DISTINCT
NEUROPATHOLOGY ASSOCIATED WITH ATLD
AND NBS!
2.1

Introduction

The developing nervous system is highly susceptible to DNA damage, and many
human syndromes caused by DNA repair deficiency present with pronounced
neuropathology (Katyal & McKinnon, 2007; McKinnon & Caldecott, 2007; Rass et al.,
2007). Within the developing nervous system, DNA DSBs pose a significant threat and
are normally repaired by either non-homologous end joining (NHEJ) or homologous
recombination (HR) (Lees-Miller & Meek, 2003; Lieber et al., 2003; West, 2003).
Coincident with repair, DNA DSBs also activate cell cycle checkpoints to pause cellular
proliferation and ensure fidelity of repair and the maintenance of genomic integrity
(Kastan & Bartek, 2004; Shiloh, 2006; Zhao et al., 2000). An alternative outcome from
DNA DSBs, and one that is frequent during neural development is the activation of
apoptosis to eliminate DNA-damaged cells (Difilippantonio et al., 2007).
Mre11/Rad50/NBS1 (MRN) and ATM (ataxia telangiectasia, mutated) are
required to coordinate the DNA DSB signaling response (Kastan & Bartek, 2004; Lavin
& Kozlov, 2007; Petrini & Stracker, 2003; Shiloh, 2006). The MRN complex rapidly
localizes to DNA DSBs, where it recruits and activates the ATM kinase to initiate DNA
damage signaling (Carson et al., 2003; Lee & Paull, 2004; Uziel et al., 2003). ATM
initiates a signaling cascade via phosphorylation of multiple substrates resulting in cell
cycle checkpoints or apoptosis (Uziel et al., 2003). In the nervous system p53 and Chk2
are particularly important (Lee et al., 2001; Takai et al., 2002). MRN modulation of ATM
activation requires protein-protein interactions with the NBS1 C-terminus (Falck et al.,
2005), although the ATM-MRN interplay is complex and likely to involve multiple
protein interactions in determining the outcome of DNA DSB signaling (Difilippantonio
et al., 2007; Stracker et al., 2007).
Underscoring the importance of the DSB response is the occurrence of diseases
when mutations render ATM, Mre11 or NBS-1 dysfunctional and result in ataxia
telangiectasia (A-T), A-T-like disease (ATLD) or Nijmegen breakage syndrome (NBS)
respectively (Kobayashi et al., 2004; McKinnon, 2004; Taylor et al., 2004). Unlike ATM,
MRE11 and NBS1 are essential during development (Xiao & Weaver, 1997; Zhu et al.,
2001), thus syndromes involving these genes result from hypomorphic mutations. A-T is
primarily characterized by cerebellar ataxia associated with Purkinje cell degeneration
!
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(McKinnon, 2004). Other phenotypic characteristics of A-T are immunodeficiency,
radiosensitivity, ocular telangiectasia, sterility and cancer predisposition. ATLD is also
characterized by neurodegeneration and radiosensitivity (Taylor et al., 2004). In contrast,
NBS features microcephaly, immunodeficiency, radiosensitivity, and cancer
predisposition (Kobayashi et al., 2004). The overlapping phenotypes of A-T, ATLD, and
NBS presumably reflect important functional interactions between ATM and the MRN
complex. However, the distinct neuropathology present in ATLD compared to NBS
indicates that the hypomorphic MRN mutations that give rise to these diseases must
ultimately lead to different downstream signaling events to account for the distinct
neuropathology. How this occurs is unknown.
Using mouse models for ATLD and NBS, an in vivo analysis of the functional
consequence of these hypomorphic mutations in the nervous system was performed.
Exogenous and endogenous genotoxic stress was induced to evaluate the relative roles of
ATM, Mre11 and Nbs1 during neural development and to investigate the signaling
defects that could account for the distinct neuropathology characteristic of each disease.
Our data show that the disease-causing mutations in MRN lead to defects in DNA
damage-induced signal transduction in the nervous system, whereby the relative
activation of apoptosis may underpin the differential neuropathology of these syndromes.

2.2 Experimental Procedures
2.2.1 Animals
To generate a conditional DNA Ligase IV allele, Dr. Helen Russell obtained a
murine BAC genomic clone (strain, 129Ola) containing an ~13kb BamHI fragment with
the Lig4 genomic locus, into which she placed a LoxP sequence into a unique MluI site
4.8kb upstream of the Lig4 ORF and a floxed NeoTK construct cloned as a HindIII
fragment ~1.7kb downstream to generate pLig4LoxP. ES cells (W9.5; 129S1/SvImJ) were
electroporated with linearized pLig4LoxP and selected with G418 antibiotic and correctly
targeted cells were identified by Southern Blot analysis. Targeted ES clones were then
electroporated with pMC-cre, followed by selection in FIAU (5-iodo-2'-fluoro-2'deoxy-1arabinofuranosyluracil) to kill cells containing TK. ES cells were then injected into
blastocysts and the resultant chimeric mice assessed for germline transmission of the
floxed Lig4 allele (St. Jude Children’s Research Hospital Transgenic Core). Nestin-cre
mice (B6.Cg-Tg(Nes-cre)1Kln/J; JAX #003771) were used to delete Lig4 throughout the
nervous system.
Animals were housed in an Association for the Assessment and Accreditation of
Laboratory Animal Care (AAALAC)-accredited facility and were maintained in
accordance with the NIH Guide for the Care and Use of Laboratory Animals. The St.
Jude Children’s Research Hospital IACUC approved all procedures for animal use.
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2.2.2 Histology and immunohistochemistry
Mice were sacrificed via transcardial perfusion using 4% paraformaldehyde
(PFA). Tissues were further fixed in 4% PFA overnight, and either cryoprotected in 25%
PBS-buffered sucrose solution and embedded in O.C.T. (Tissue-Tek) or paraffinembedded. Frozen tissue was sectioned at 10 µm thickness using a Microm HM500 M
cryostat. Paraffin-embedded spinal cord samples were sectioned at 40 µm thickness using
a Microm HM 325.
Antigen retrieval was used for all immunohistochemistry using the anti-phospho"H2AX (1:500; Abcam), anti-53BP1 polyclonal (1:500; Bethyl laboratories), anti-p53
(CM5; 1:500; Vector Laboratories); anti-p53 phospho-Ser-15 (1:500; Cell Signaling), and
anti-active caspase 3 (1:500; BD Biosciences) antibodies. For immunofluorescent
staining, sections were subsequently immunolabelled with Cy3-conjugated goat antimouse (1:400; Jackson Immunoresearch) and/or FITC-conjugated goat anti-rabbit
secondary antibodies (1:500; Jackson Immunoresearch) and mounted with Vectashield
anti-fade reagent containing DAPI (Vectorlabs). Immunohistochemistry for activated
caspase-3 or p53-ser15 was performed overnight at room temperature after quenching
endogenous peroxidase activity with 0.6% hydrogen peroxide in methanol.
Immunoreactivity was visualized with a vasoactive intestinal peptide substrate kit (V.I.P.;
Vector Labs) according to the manufacturer's directions after tissues were treated with
biotinylated secondary antibody and avidin DH-biotinylated horseradish peroxidase-H
complex (Vectastain Elite kit; Vector Labs). Sections were counterstained with 0.1%
methyl green (Vector Labs), dehydrated, and mounted in DPX reagent. Apoptotic cells
were detected with ApopTag Fluorescein in situ apoptosis detection kit (Chemicon
international) according to the manufacturer’s instructions. "H2AX and 53BP1 foci were
quantitated manually under the microscope at 400x magnification. Quantitation of
TUNEL or caspase-3 positive cells was determined by counting positive signal from
images equivalent in size and magnification between genotypes. Images were captured
using an Axioskop 2.0 microscope (Carl Zeiss) and a SPOT camera (Diagnostic
Instruments, Inc).

2.2.3 Astrocyte culture
Cerebral cortices were isolated from P4 mice and placed into a 35 mm dish
containing ice cold 1:1 mix of Dulbecco’s modified Eagle’s medium and Ham’s nutrient
mixture F-12 (DMEM-F12; Gibco) supplemented with 2 mM L-glutamine, 100 U/mL
penicillin, and 100 µg/mL streptomycin. Meninges were removed under a dissecting
microscope and cortices were transferred to a new dish containing fresh media mix as
described above. Cortices were dissociated by passage through a 5mL pipette, then
centrifuged at 1000 rpm for 5 min. Cells were resuspended in DMEM-F12 supplemented
with 10% fetal calf serum, 2 mM L-glutamine, 100 U/mL penicillin, 100 µg/mL
streptomycin, and 20 #g/mL epidermal growth factor (Sigma). Astrocytes were allowed
to establish in Primeria T-25 tissue culture flasks (Falcon) at 37°C in a humidified
incubator. Medium was refreshed after 4 days in culture and cells were trypsinized at
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100% confluence (typically ~1 week post-isolation). Cells were seeded onto 4-chambered
poly-D-lysine coated slides (Falcon) at 2x104 cells/chamber and allowed to establish for 2
days prior to treatment and staining.
Cells were irradiated using a Gammacell® 40 Exactor (MDS Nordion). Following
irradiation, slides were returned to incubator. After the designated recovery time, cells
were washed in PBS for 5 min at RT, then fixed in 3% PFA/ 0.2% triton-X100 for 15 min
at 4 °C. Blocking solution (1.5% milk in PBS) was applied for 1 hr at RT, followed by
incubation with anti-phospho-"H2AX (1:1000; Abcam) overnight at 4 °C. Primary
antibody solution was aspirated from slide chambers, and cells were washed in PBS.
Cells were subsequently immunolabelled with FITC-conjugated goat anti-rabbit
secondary antibodies (1:500; Jackson Immunoresearch) and mounted with Vectashield
anti-fade reagent containing DAPI (Vectorlabs). Images were captured at 400x
magnification using an Axioskop 2.0 microscope (Carl Zeiss) and a SPOT camera
(Diagnostic Instruments, Inc). Quantitation of foci was performed using the Adobe®
Photoshop® plugin Image Processing Tool Kit (Reindeer Graphics, Inc.).

2.2.4 Real-time PCR
Genomic DNA was phenol/chloroform extracted from frozen sections and
suspended in TE buffer. DNA concentration was determined from the A260 as measured
using an Ultrospec 2000 UV/Visible Spectrophotometer (Pharmacia Biotech). Standard
DNA was serially diluted at 1:5 from a starting concentration of 100#g/µL. Unknown
samples were diluted to 100#g/µL, such that each reaction contained an equal amount of
DNA. DNA was added to iQ™ SYBR® Green supermix (BioRad) containing forward
and reverse primers for either the Lig4 coding region or $-actin. PCR reaction was
carried out using the iQ™5 Multicolor Real-Time PCR Detection System (BioRad).
Measurement numbers were automatically assigned based on SYBR green amounts fit to
a standard curve. The amount of Lig4 product was normalized to that of $-actin for each
sample.
Lig4 forward primer: 5’ ACTATACCGACCAGTTTGGTGAATC
Lig4 reverse primer: 5’ CCCGAACGCATTGTGAATAA
!-actin forward primer: 5’ CAGCAAGCAGGAGTACGATGAG
!-actin reverse primer: 5’ CAGTAACAGTCCGCCTAGAAGCA

2.3

Results
2.3.1 Kinetics of H2AX phosphorylation in Atm, Mre11, Nbs1, or
Lig4-deficient astrocytes

Histone H2A is conserved between eukaryotes and is classified into the
subfamililies H2A1, H2A2, H2AZ, and H2AX. The NH2- and COOH- tails are targets for
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post-translational modifications including phosphorylation, methylation, acetylation, and
ubiquitination (Takahashi & Ohnishi, 2005). Phosphorylation of H2AX serine 129 at the
–COOH terminus is one of the first responses to DNA DSBs, occurring within 3 minutes
following irradiation. This phosphorylation event has been attributed to overlapping
activity between ATM and DNA-PKcs in non-replicating cells (Kuhne et al., 2004;
Rogakou et al., 1998; Stiff et al., 2004). The modified histone is termed "-H2AX, and can
be visualized through immunoflourescence as punctate nuclear foci. Pulse-field gel
electrophoresis (PFGE) is an established method of measuring DSBs that has been shown
to correlate with the amount of "-H2AX foci observed in cells after irradiation, and is
thus widely used as a quantitative measure of DSB repair. Both methods were employed
to study repair defects in fibroblasts isolated from an A-T individual and a LIG4
syndrome patient. The A-T cells showed no deficient repair based on PFGE and
prolonged persistence of "-H2AX foci after IR. In contrast, the LIG4 syndrome cells
showed proficient repair even several days after prolonged exposure to IR (Kuhne et al.,
2004).
Astrocytes were isolated from Lig4Nes-cre, Atm-/-, Mre11ATLD1/ATLD1, and Nbs1!B/!B
post-natal day 4 (P4) pups to compare the DNA damage response in murine neural cells.
In contrast to the Kuhne et al. report of proficient resolution of DSBs in LIG4 syndrome
fibroblasts, Lig4Nes-cre astrocytes showed increased presence of "-H2AX foci in untreated
cells and dramatic persistence of foci over a prolonged recovery time. This difference
from the LIG4 syndrome fibroblasts reflects the diminished repair capacity associated
with LIG4 hypomorphic mutations, in contrast to complete loss of Lig4. Thus, Lig4Nes-cre
astrocytes served as a positive control for DNA DSB repair deficiency. Concurrent with
reported findings in A-T fibroblasts, Atm-/- astrocytes showed abrogated H2AX
phosphorylation at earlier times post-IR, but there was a statistically insignificant
increase in residual foci 6 hours post-IR perhaps suggesting a minor DSB repair
deficiency. Because ATM is reportedly the major kinase responsible for H2AX
phosphorylation (ATR and DNA-PK share H2AX as a common substrate as well), we
reasoned that the Mre11ATLD1/ATLD1 and Nbs1!B/!B mutations would mimic repair kinetics
in Atm-/- astrocytes if Atm activity was compromised (Burma and Chen, 2004; Stiff et al.,
2004; Wang et al., 2005b). Mre11ATLD1/ATLD1 astrocytes showed a pattern of H2AX
phosphorylation that was largely indistinguishable from that seen in the Atm-/- cells.
Nbs1!B/!B astrocytes showed a less pronounced abrogation of H2AX phosphorylation 10
min post-IR than observed in either the WT or Mre11ATLD1/ATLD1 cells. However, 6 hours
post-IR, the Nbs1!B/!B astrocytes showed a statistically insignificant increase in the
number of residual foci compared to the WT control (Figures 2.1 and 2.2). Variability
and large standard deviations make this data difficult to interpret, thus firm conclusions
cannot be drawn from it.

2.3.2 IR-induced apoptosis is defective in the Mre11ATLD1/ATLD1 brain
To determine the basis for the differential neuropathology associated with ATLD
and NBS we used mice harboring hypomorphic alleles (Mre11ATLD1/ATLD1 and Nbs1!B/!B)
corresponding to the human diseases (Carney et al., 1998; Stewart et al., 1999; Varon et
14

Figure 2.1 Kinetics of H2AX phosphorylation in Lig4Nes-cre, Atm-/-, Mre11ATLD1/ATLD1,
and Nbs1!B/!B astrocytes.
Astrocytes were generated from P4 mice of the indicated genotypes. Cells were seeded
onto chambered slides and allowed to grow 48 hours prior to being either mock treated or
irradiated at a dose of 3 grays (Gy). Cells were allowed to recover for the indicated times,
then were stained via indirect immunofluorescence against "-H2AX (green). Nuclei were
counterstained with DAPI (blue). Images were taken at 400x magnification.
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Figure 2.2 DNA DSB repair kinetics in Lig4Nes-cre, Atm-/-, Mre11ATLD1/ATLD1, and
Nbs1!B/!B astrocytes.
"-H2AX foci were quantified from the images represented in Figure 2.1 using the
Adobe® Photoshop® plugin Image Processing Tool Kit (Reindeer Graphics, Inc.). Error
bars represent standard deviation between the results of 2 independent experiments
performed with cells isolated from different animals. For each experiment, foci were
counted in no less than 20 cells per genotype.
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al., 1998). The ATLD mutation (633R!STOP) results in a truncated Mre11 protein,
while the NBS mouse has a truncating mutation of Nbs1 that produces an 80 kDa protein
lacking the N-terminal FHA and BRCT domains (Theunissen et al., 2003; Williams et al.,
2002). These mice recapitulate many aspects of the respective human syndromes
including radiosensitivity and cell cycle checkpoint defects, although they do not develop
overt neuropathology (Theunissen et al., 2003; Williams et al., 2002).
While many features of NBS and ATLD can be attributed to a defect in ATM
activation (Carson et al., 2003; Difilippantonio et al., 2005; Uziel et al., 2003), the
disparate neuropathology suggests differences in DNA damage signaling in the nervous
system. To investigate DNA damage responses in the developing nervous system of
ATLD and NBS mice, we used ionizing radiation (IR) to induce genotoxic stress.
Because apoptosis is a primary readout of IR-induced DNA damage in the developing
nervous system (Difilippantonio et al., 2007), we analyzed this in the postnatal retina and
dentate gyrus using immunohistochemistry to assess caspase-3 activation. In the absence
of radiation no caspase-3 positive cells were seen (Figure 2.3). However after radiation,
wild type (WT) and Nbs1!B/!B mice showed an equivalent susceptibility to IR-induced
apoptosis (Figure 2.3A c-f). In contrast, there was a marked resistance to apoptosis in the
Mre11ATLD1/ATLD1 mice (Figure 2.3A g,h). IR-induced cell death was substantially
reduced throughout immature postmitotic regions of the Mre11ATLD1/ATLD1 developing
nervous system, including the inner nuclear layer of the retina and the dentate gyrus of
the hippocampus (Figure 2.3A g, h). The resistance of these particular cell populations is
similar to that observed in the same regions in the Atm-/- brain (Herzog et al., 1998; Lee et
al., 2001). IR treatment of Mre11ATLD1/ATLD1 (and Atm-/-) embryos at E13.5 and E15.5 also
showed resistance to apoptosis in immature, postmitotic neurons akin to the P5 tissues,
while in Nbs1!B/!B embryos IR-induced apoptosis was indistinguishable from WT
embryos. Importantly, IR-induced apoptosis in the proliferating ventricular zone of the
embryonic nervous system occurred normally in Mre11ATLD1/ATLD1 (and Nbs1!B/!B) as it
does in Atm-/- tissue (data not shown). Thus, ATLD but not NBS mutations measurably
influence DNA damage-induced apoptosis in specific regions of the developing brain.
Because the MRN complex can modulate ATM kinase activity, we determined if
the resistance to IR-induced apoptosis in the Mre11ATLD1/ATLD1 tissue was related to
defective Atm activity. Dr. Youngsoo Lee, in the McKinnon lab, assayed Atm ser1987
phosphorylation (equivalent to ser1981 of human ATM) as a marker for DNA damageinduced Atm activation in vivo in Mre11ATLD1/ATLD1 and Nbs1!B/!B P5 cerebellum, a tissue
significantly affected in both diseases. At doses of 1Gy or below, very little Atm ser1987
phosphorylation was observed in either Mre11ATLD1/ATLD1 or Nbs1!B/!B tissue compared to
WT cerebellum (Figure 2.4A). However, at higher radiation levels (>4Gy) Atm
phosphorylation was evident in Mre11ATLD1/ATLD1 and Nbs1!B/!B tissue, albeit reduced
compared to WT (Figure 2.4A). These data indicate that both Mre11 and Nbs1 mutations
result in reduced Atm ser1987 phosphorylation, indicating MRN modulates Atm
signaling in the developing brain. As Nbs1!B/!B neural tissue underwent IR-induced
apoptosis similar to WT (Figure 2.3), defective Atm phosphorylation was somewhat
unexpected. Therefore, we confirmed disruption of the MRN complex in
Mre11ATLD1/ATLD1 and Nbs1!B/!B tissue. Jingfeng Zhao, in the McKinnon lab, showed that
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Figure 2.3 Radiation-induced apoptosis in Mre11ATLD1/ATLD1 and Nbs1!B/!B CNS.
(A) WT, Mre11ATLD1/ATLD1 and Nbs1!B/!B mice were treated with 8Gy of "-irradiation and
collected 6 hr post-IR. Immunostaining was performed against active-caspase 3. Images
of the retina (a, c, e, g) are at 400x magnification. Images of the dentate gyrus (b, d, f, h)
are at 200x magnification. Retinal photoreceptor layer (PR), inner nuclear layer (INL),
plexiform layer (PL) are indicated. Arrows point to immunopositive cells. (B)
Quantitation of the total number of active-caspase 3 positive cells in the retina. Error bars
represent standard deviation. (C) Quantitation of the total number of active-caspase 3
positive cells in the dentate gyrus. Error bars represent standard deviation.
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Figure 2.4 DNA damage responses in the Mre11ATLD1/ATLD1 and Nbs1!B/!B nervous
systems.
(A) WT, Mre11ATLD1/ATLD1, and Nbs1!B/!B mice were treated with indicated doses of "irradiation and cerebella were harvested 30 min post-IR. Total Atm was
immunoprecipitated from cerebellar lysates followed by immunoblotting against Atm
pSer1987. Total Atm served as the loading control. Corrections were made for loading by
normalization of Atm pSer1987 bands to total Atm. Quantitative analysis depicted under
the Atm pSer1987 bands. (B) WT, Mre11ATLD1/ATLD1, and Nbs1!B/!B mice were treated
with indicated doses of "-irradiation and cerebella were harvested 3 hr post-IR.
Cerebellar lysates were probed using antibodies recognizing Nbs1, Mre11 and Chk2.
Phosphorylated Chk2 (pChk2) was detected as a mobility shift. $-actin was the loading
control. (C) WT, Mre11ATLD1/ATLD1, and Nbs1!B/!B mice were treated with 18 Gy of "irradiation and sacrificed 4 hr post-IR. Immunostaining was performed against p53phosphoserine 18 and active-caspase 3. Micrographs depict cerebellum and are at 200x
magnification. (D) WT, Atm-/- and Mre11ATLD1/ATLD1 were treated with 4Gy of IR to
determine Chk2 and p53 phosphorylation in Atm-/- cerebellum. (E) WT, Mre11ATLD1/ATLD1
and Nbs1!B/!B mice were treated with 18Gy of "-irradiation and collected 3 hr post-IR.
Cerebellar lysates in D and E were probed for Chk2, p53 (pSer18) and Nbs1 or Mre11.
Ponceau staining was used to determine equal loading. The p53(s18) levels were
normalized to the upper band of the Ponceau stain, as indicated by numbers above the
bands.
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full length Nbs1 was not present in the Nbs1!B/!B samples (Figure 2.4B), although he did
detect the 80 kDa product translated from the Nbs1 mutant message (Maser et al., 2001).
Similarly, the COOH-terminus of Mre11 was not detected in Mre11ATLD1/ATLD1 tissue and
levels of Nbs1 were also substantially reduced (Figure 2.4B). Consequently, we
determined other readouts of Atm signaling relevant to apoptosis. Chk2 is a key DNA
damage signaling effector that is activated by Atm-dependent phosphorylation (Ahn et
al., 2000; Hirao et al., 2000; Matsuoka et al., 2000), and is essential for radiation-induced
apoptosis in the developing nervous system (Takai et al., 2002). In both Mre11ATLD1/ATLD1
and Nbs1!B/!B tissues, Mr. Zhao found that there was clearly less Chk2 modification
compared with WT after irradiation. However, despite this, Chk2 activation was
substantially greater in the Nbs1!B/!B tissue compared to Mre11ATLD1/ATLD1 particularly
after 8Gy (Figure 2.4B). We also evaluated ser-18 phosphorylation of p53 (equivalent to
serine-15 of human p53) after radiation of P5 cerebellum using immunohistochemistry
and western blot analysis. While both WT and Nbs1!B/!B tissue had robust induction of
p53 ser18 phosphorylation and caspase-3 activation, both were markedly reduced in
Mre11ATLD1/ATLD1 tissue (Figure 2.4C). Furthermore, Mr. Zhao also determined the
relative level of Chk2 activation in Atm-/- P5 cerebellum, as a comparison to the MRN
mutants, and found that no Chk2 activation or p53ser18 phosphorylation occurred after
4Gy of IR, consistent with apoptosis being Atm-dependent in this tissue (Figure 2.4D).
Additionally, he found that at higher radiation doses (18Gy) the difference between Chk2
activation in Mre11ATLD1/ATLD1 and Nbs1!B/!B is more apparent, as is, albeit to a lesser
degree, phosphorylation of p53ser18 (Figure 2.4E). The abundant apoptosis and Chk2
modification observed in the Nbs1!B/!B mice indicate that the hypomorphic Nbs1 allele
can activate Atm sufficiently to engage apoptosis in the CNS after DNA damage. We
also observed defects in Atm signaling in the Mre11ATLD1/ATLD1 and Nbs1!B/!B thymus,
with reduced apoptosis in ATLD tissue (data not shown), consistent with recent data
using Mre11ATLD1/ATLD1 thymocytes (Stracker et al., 2008). Thus, the MRN complex is
required for ATM activation, and this is defective in both Mre11ATLD1/ATLD1 and Nbs1!B/!B
tissue. However, the Mre11ATLD1/ATLD1 mutation results in a more substantial block in Atm
activation that includes abrogation of apoptosis.

2.3.3

Characterization of Lig4Nes-cre mice

The Lig4Nes-cre animal model was generated to be used as a tool in which to study
the chronic consequences of endogenously-occurring DNA damage in the nervous
system. Dr. Helen Russell generated the mice through restriction enzyme-mediated
cloning and performed southern and northern blots using DNA extracted from various
tissues of embryonic to P5 aged mice to confirm efficiency and specificity of gene
deletion in the Nestin-cre background. I used real-time PCR analysis to verify deletion of
the Lig4 open reading frame in the E13.5 CNS (Figure 2.5).
Lig4Nes-cre mice were born at the expected frequency and were viable into
adulthood. Initial histological analysis revealed pronounced microcephaly, but largely
normal cellular and gross morphology (Figure 2.6). Though apparently healthy, it was
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Figure 2.5 Real-time PCR demonstrating Lig4 gene excision in E13.5 Lig4Nes-cre CNS.
Embryonic brain and spinal was isolated from cryosections. DNA was phenol/chloroform
extracted. Error bars represent standard deviation between duplicate results using DNA
from the same sample.

Figure 2.6 Diminished cerebellar size reflective of overall microcephaly in Lig4Nes-cre
mice.
Five month old Lig4Ctrl and Lig4Nes-cre mice were transcardially perfused and frozen
sections (10 µm thick) were stained for hematoxylin and eosin (H&E). Photomicrographs
were taken at 25x magnification.
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noticed that Lig4Nes-cre females tended to produce small litters often with less than 5 pups
and ceased to efficiently reproduce around 4 months of age. In addition, two Lig4Nes-cre
males that were placed with healthy Lig4+/loxP females not expressing cre failed to mate.
Notably, around 4 months of age these animals began to appear vaguely unhealthy (i.e.,
rough coat and lethargic). Between 4-6 months of age all Lig4Nes-cre began to develop
mild hindlimb ataxia most noticeable as loss of balance that progressed to an inability to
move the hindlimbs forward such that dragging the legs was the only means of mobility.
Full hindlimb paralysis was not observed either because the pathology had not progressed
to its full extent at the time of euthanasia or the mechanism behind this phenomenon
failed to cause paralysis. This phenotype was observed in all Lig4Nes-cre animals aged to at
least 1 year (at least 20 animals) and was not seen in an equal number of age-matched
controls. Despite dramatic phenotypic penetrance, no neuropathology was found that
would account for this presentation. No degeneration was observed in adult Lig4Nes-cre
brain or spinal cord based on TUNEL and FluoroJade C staining (data not shown).
Presentation appeared consistent with spinal cord damage, thus analysis of the vertebrae
and spinal cord was performed. In conjunction with the St. Jude Children’s Research
Hospital Animal Imaging Center, CT scans were taken of the entire vertebral column of
Lig4Nes-cre mice that exhibited severe hindlimb impairment and age-matched controls to
determine if bone malformations might have caused compression of the spinal cord
(Figure 2.7). No evidence of such occurrence was observed (Personal communication
with Dr. Chris Calabrese, April 18, 2007).
Histology of the lumbar spinal cord was performed. Toluidine blue staining was
used to assess white matter tracts and Nissl stain was used to look at neuronal soma.
Neither stain revealed evidence of pathology (data not shown). Similarly, H&E staining
failed to detect degenerative changes in the LigNes-cre spinal cord and immunostaining
against myelin basic protein showed normal patterns of myelination compared to agematched and sex-matched Lig4Ctrl samples (Figure 2.8). Cellularity did appear to be
decreased in the spinal cord, based upon H&E staining. This was not confirmed through
quantitation and likely reflects cell loss during development. All panels were taken at the
same magnification. H&E panels taken at low magnification demonstrate that similar to
microcephaly observed in the LigNes-cre mice, the spinal cord is much smaller compared to
controls.
Though Lig4-/- embryos exhibited extensive Atm/p53-dependant apoptosis in the
nervous system prior to death, it has not been formally shown (though assumed) that the
accumulation of unrepaired DSBs were the reason for cellular demise. The Lig4Nes-cre
mice were valuable as a tool with which the inherent occurrence and consequences of
DNA damage could be observed in the mammalian nervous system from embryonic life
through adulthood. Similar to the DNA damage response described in astrocytes,
immunostaining against "-H2AX and 53BP1 was used to track the appearance and
resolution of DNA damage. Failed attempts were made at performing pulsed-field gel
electrophoresis directly upon tissue samples to corroborate immunostaining (data not
shown). Foci were rarely observed in Lig4Ctrl animals and typically appeared only in a
few cells throughout the entire brain (Figures 2.9-2.11). In those few cells, less than five
foci were typically observed. Spatiotemporal mapping of foci in Lig4Nes-cre mice revealed
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Figure 2.7 CT scan of spinal column collected from Lig4Nes-cre mouse with end-stage
hindlimb ataxia and age-matched Lig4Ctrl.
Personal communication with Dr. Chris Calabrese, April 18, 2007.
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Figure 2.8 Histology observed in Lig4Nes-cre spinal cord.
Upper panels show H&E stained paraffin sections of 12 month old Lig4Ctrl and Lig4Nes-cre
spinal cord (25x magnification). Insets of the dorsal horn are shown in the lower left
corner of each panel (200x magnification). Lower panels show dorsal horn of 12 month
old Lig4Ctrl and Lig4Nes-cre spinal cord immunostained against myelin basic protein (400x
magnification).
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Figure 2.9 Pattern of 53BP1 foci in E15.5 Lig4Nes-cre brain.
53BP1 were observed in the indicated areas of the Lig4Nes-cre embryonic brain. Agematched Lig4Ctrl samples showed diffuse nuclear staining of 53BP1 (A, C, E insets)
rather than punctuate foci (B, D, F insets). Photomicrographs were captured at 200x
magnification.
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Figure 2.10 Comparison of 53BP1 foci in caudate putamen of P5, 4 month old, and
12 month old Lig4Nes-cre mice.
Photomicrographs were captured at 200x magnification. Arrows indicate distinct foci.
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Figure 2.11 Comparison of "-H2AX expression in cerebella of P4, 4 month old, and
12 month old Lig4Nes-cre mice.
Photomicrographs were captured at 200x magnification.
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that DNA DSBs arise during embryogenesis and continue to accumulate during
adulthood (up to 1 year of age) in the brain (Figures 2.9-2.12). Semi-quantitative
mapping throughout major regions of the postnatal and adult Lig4Nes-cre brains revealed
that there is no striking regional or cell-type specificity in which damage occurs.
While endogenous DNA repair foci allowed us to see where damage occurs
naturally in the brain, it provided only a snapshot in time of existing damage without
indication of whether DSBs were being left unrepaired and accumulating, or if
endogenous damage was occurring with a higher frequency in older animals. Given the
role of Lig4 in NHEJ, 53BP1 and "-H2AX foci observed endogenously in the Lig4Nes-cre
mice most likely represent the former. To ascertain the likelihood of this, repair capacity
was measured in vivo through irradiation and prolonged recovery of age-matched Lig4Nescre
and Lig4Ctrl mice followed by immunostaining against 53BP1 (data not shown) and "H2AX (Figure 2.13). The results of this experiment indicated that little or no repair
occurred in the LigNes-cre brain up to 7 days post-IR, further suggesting that no significant
back-up method of NHEJ exists in the nervous system.
In summary, the Lig4Nes-cre mutant is a viable mouse model of DNA ligase IV
deficiency in the nervous system. Though microcephalic, these mice do not exhibit any
other notable neuropathology. Microcephaly is likely attributable to increased apoptosis
during neurogenesis, due to an overload of DNA DSBs in nascent post-mitotic cells.
Despite the overwhelming presence of DNA damage in the adult Lig4Nes-cre brain,
apoptosis is not induced (data not shown). Thus, the unexplained hindlimb ataxia is
difficult to directly relate to DNA damage, though how the accumulation of DNA DSBs
affects function of viable neurons is unknown.

2.3.4 Microcephaly after Lig4 loss requires Atm signaling
In comparison to age-matched and sex-matched littermates Lig4Ctrl (Lig4+/loxP;
Nestin-cre or Lig4loxP/loxP), Lig4Nes-Cre animals exhibit pronounced microcephaly as
evident by an approximately 40% reduction in brain size (Figure 2.14). Notably,
microcephaly is a characteristic of LIG4 syndrome patients with hypomorphic mutations
in LIG4 (O'Driscoll et al., 2004). To determine the cause of the microcephaly in the
Lig4Nes-Cre mice we assessed apoptosis at various developmental stages, and found that
from E13.5 onwards there was markedly increased apoptosis in Lig4Nes-Cre neural tissue
as judged by TUNEL and caspase 3 staining (Figure 2.15), with a peak around E15.5
somewhat similar to germline disruption of Lig4. Thus, microcephaly in Lig4Nes-Cre mice
likely results from apoptotic cell loss during development. Therefore we generated
Lig4Nes-Cre;Atm-/-, Lig4Nes-Cre;Mre11ATLD1/ATLD1 or Lig4Nes-Cre;Nbs1!B/!B mice to produce
viable mice with which to monitor longer term consequences of MRN mutations.
Initially, we confirmed that both MRN mutations produced effects in the Lig4Nes-cre mice
similar to those we observed after germ line disruption of Lig4. Apoptosis was abrogated
in Lig4Nes-Cre;Mre11ATLD1/ATLD1 and Lig4Nes-Cre;Atm-/- but occurred to the same level as
Lig4Nes-Cre in Lig4Nes-Cre;Nbs1!B/!B mice (Figure 2.15). To assess the long-term
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Figure 2.12 Spatiotemporal mapping of 53BP1 and H2AX foci in Lig4Nes-cre brains.
Foci were semi-quantitated manually at 400x magnification in the indicated regions of
the brain at the indicated ages in Lig4Ctrl and Lig4Nes-cre samples. Data is shown for the
Lig4Nes-cre samples. As pictured in Figures 2.9 and 2.10, almost no cells contained DNA
either 53BP1 or "-H2AX foci. Because the adult cerebellum contains only the granule
cell layer, as the EGL no longer exists and the IGL is mature, these structures are
designated as non-applicable in the 4mo and 12mo samples. That is indicated under the
cerebellar granule cell layer in adult samples. Data is representative of 2 animals for each
age analyzed.
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Figure 2.13 "-H2AX foci persist in irradiated Lig4Nes-cre brain.
Littermate Lig4Ctrl and Lig4Nes-cre mice were either untreated or irradiated with 8 Gy IR at
age P21. Irradiated animals were allowed to recover for either 1 or 7 days prior to
collection of brains. Immunostaining was performed against "-H2AX (red) and nuclei
were stained with DAPI (blue). Two animals were assessed for each recovery time.
Photomicrographs were captured at 200x magnification.
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Figure 2.14 Mre11 hypomorphism and Atm loss partially rescue microcephaly in
Lig4Nes-cre mice.
Measurement of A-T, A-TLD, and NBS mutations towards Lig4Nes-Cre brain size. Brain
weights were collected from sex-matched cohorts at 4 months of age. Error bars represent
standard deviation, and “n” is the total number of animals.
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Figure 2.15 Apoptosis in E15.5 Lig4Nes-cre brain in Atm-/-, Mre11ATLD1/ATLD1, and
Nbs1!B/!B genetic backgrounds.
TUNEL analysis and immunostaining for active caspase 3 were performed on E15.5
embryos from indicated genotypes. The total number of positive cells per 400µm2 was
quantified. Error bars represent standard deviation. Micrographs show ganglionic
eminence and neopallial cortex at 200x magnification.
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consequences of MRN dysfunction and chronic DNA damage in the CNS, we monitored
adult Lig4Nes-Cre;Atm-/-, Lig4Nes-Cre;Mre11ATLD1/ATLD1 or Lig4Nes-Cre;Nbs1!B/!B mice.
Inactivation of either Atm or Mre11 significantly rescued microcephaly, whereas the
Nbs1!B/!B mutation had no obvious affect towards microcephaly in Lig4Nes-Cre mice
(Figure 2.14). Excluding microcephaly, no other significant morphologic aberrations
were found in the Lig4Nes-Cre brain. However, with age, adult Lig4Nes-Cre animals
developed a severe hindlimb ataxia of unknown etiology from 7-9 months onwards.
Neither the Atm-/-, Mre11ATLD1/ATLD1, nor Nbs1!B/!B background affected latency or
severity of this phenotype, suggesting this later pathway is independent of MRN/ATM.
Thus, the microcephalic phenotype in Lig4Nes-Cre mice is attributable to increased
apoptosis via ATM dependent DNA damage signaling.

2.4

Discussion

Defective responses to DNA damage resulting from dysfunction of ATM or the
MRN complex can cause the human syndromes A-T, ATLD, and NBS. Although these
diseases share similar phenotypes including radiosensitivity and chromosomal instability,
A-T and ATLD exhibit neurodegeneration while NBS is characterized by microcephaly.
This suggests that the respective disease-causing mutations impact DNA damage
signaling differently within the brain. To test this, we analyzed the DNA damage
response in the nervous systems of ATLD (Mre11ATLD1/ATLD1) and NBS (Nbs1!B/!B) mice
and found that different effects upon ATM activation and downstream apoptotic
signaling distinguish these MRN mutations. Therefore, we hypothesize that the different
neuropathology in ATLD and NBS is a result of the relative levels of ATM activation by
MRN after DNA damage, most probably in response to DNA DSBs.
While both Mre11ATLD1/ATLD1 and Nbs1!B/!B are defective in Atm phosphorylation
after DNA damage, only Mre11ATLD1/ATLD1 mutations block the subsequent activation of
apoptosis by Atm. In this manner, the Mre11ATLD1/ATLD1 mutation creates a scenario
similar to the Atm-/- nervous system whereby defective ATM signaling inhibits apoptosis
of DNA-damaged neural cells (Lee et al., 2001). Therefore our data provide a
mechanistic explanation for the similar neuropathology between A-T and ATLD. We
have previously suggested that the loss of ATM prevents apoptosis, leading to
incorporation of cells harboring genomic damage into the mature nervous system, and
over time these cells presumably succumb to this damage and die (Herzog et al., 1998;
Lee et al., 2001). Thus, attenuation of DNA damage-dependent apoptosis in ATLD would
mimic A-T, resulting in neurodegeneration characteristic of each disease.
Conversely, in NBS, DNA damage accumulates due to dysfunctional MRN, but
Nbs1 mutations do not block Atm-dependent apoptosis and therefore we predict that
increased apoptosis occurs during development contributing to microcephaly. This is
consistent with defective NBS1 leading to increased genotoxic stress, cancer and
radiosensitivity (Kobayashi et al., 2004). As opposed to the Nbs1!B/!B mice, complete
disruption of Nbs1 in the murine nervous system leads to microcephaly from DNA
damage-induced apoptosis and decreased proliferation (Frappart et al., 2005). In contrast
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to the microcephaly observed in LIG4 syndrome and modeled in the Lig4Nes-cre mice,
neuropathology associated with NBS could be due to damage accumulation in either
post-mitotic or proliferating cells as NBS1 is also important during HR (Limbo et al.,
2007; Sartori et al., 2007; Tauchi et al., 2002). The Nbs1!B allele results from deletion of
exons 4 and 5, producing a protein that lacks the N-terminal FHA and BRCT domains
encoded within exons 1 through 5. In contrast to the Nbs1!B/!B mouse, other models that
lack a C-terminus (Nbs1!C/!C and Nbs1tr735), showed reduced apoptosis in some tissues
consistent with a defect in ATM activation (Difilippantonio et al., 2007; Stracker et al.,
2007). Additionally, deletion of the Nbs1 C-terminus in the context of the Nbs1%B protein
(the Nbs1!BC allele) results in apoptotic defects in thymocytes but does not rescue
gestational lethality associated with Lig4 loss (data not shown) which is linked to
neuraxis-wide apoptosis, suggesting that modulation of apoptosis by Nbs1 is tissuespecific.
As NBS individuals harbor mutations in the FHA and BRCT domains, not the Cterminus, the pathology associated with NBS involves an intact C-terminus. Preservation
of the C-terminus presumably allows interaction of the resulting NBS1 protein with ATM
and Mre11, and the activation of apoptosis. Although the level of Nbs1 is reduced in
Mre11ATLD1/ATLD1 cells, there is still a relatively higher level than that of the NBS1 p80
protein found in Nbs1!B/!B tissue. This suggests that the apoptotic defect we observe in
the Mre11ATLD1/ATLD1 nervous system directly involves the Mre11 mutant protein rather
than an indirect effect upon Nbs1. Given the multiple contacts ATM makes with the
MRN complex, it is likely that ATLD mutations directly and selectively impact ATMMRN interactions to preclude effective ATM activation (Lee & Paull, 2004).
Why then do A-T and NBS have many phenotypic similarities outside of the
nervous system? These similarities encompass immunodeficiency, cancer and
radiosensitivity, and reflect the interrelated roles of MRN and ATM during DNA
rearrangements in the immune system and maintenance of genomic integrity in
proliferating cells. For example, ATM and NBS1 are required to ensure the fidelity of
programmed rearrangements and elimination of cells with inappropriate genomic
rearrangements in the immune system (Bredemeyer et al., 2006; Callen et al., 2007;
Jankovic et al., 2007; Kracker et al., 2005; Reina-San-Martin et al., 2005). Additionally,
both ATM and NBS1 can function in stem and progenitor populations in the
hematopoietic and germ cell compartments (Ito et al., 2004; Kang et al., 2002; Takubo et
al., 2008). These requirements for ATM and NBS1 contrast the situation in the nervous
system where ATM fulfills an indispensable role in DNA damage-induced apoptosis in
postmitotic neurons, but not in proliferating neural progenitors where ATR or DNA-PK
may be the more important kinases (Lee et al., 2001; Orii et al., 2006).
In summary, our data demonstrate that the respective MRN mutations that lead to
NBS and ATLD impact differently upon ATM signaling. These data illuminate the
mechanistic underpinnings of the different neuropathology present in ATLD and NBS,
suggesting they result from alterations in the modulation of ATM-dependent apoptosis
after DNA damage (Shull et al., 2009).
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CHAPTER 3 ATR IS REQUIRED FOR GENOMIC
INTEGRITY AND PROLIFERATION OF NEURAL
PROGENITORS
3.1

Introduction

The three major phosphoinositol 3-kinase (PI3K)-related protein kinases (PIKKs)
involved in signal transduction of the DNA damage response are ataxia-telangiectasia
mutated (ATM), ATM and RAD3-related (ATR), and DNA-Protein Kinase catalytic
subunit (DNA-PKcs). ATM and ATR are highly similar in structure and share many
overlapping substrates. Both kinases have a preference for phosphorylating serine or
threonine residues that are followed by a glycine (Cimprich & Cortez, 2008). Recent
proteomic analysis identified about 700 substrates phosphorylated on ser-gln and thr-gln
sites recognized by ATM and ATR, in response to DNA damage. A few examples of
such substrates include FANCD2, MDC1, 53BP1, and Orc3 (Matsuoka et al., 2007).
ATR has also been reported to phosphorylate both Chk1 and Chk2 (a major ATM
substrate) in response to cisplatin (Pabla et al., 2008). Additionally, both ATR and ATM
reportedly phosphorylate p53 as well (Banin et al., 1998; Khanna et al., 1998; Tibbetts et
al., 1999). Despite these similarities, ATM and ATR are functionally distinct, as evident
by early embryonic lethality of Atr-/- mice versus the viability of Atm-/- mice (Barlow et
al., 1996a; Brown and Baltimore, 2000; Brown et al., 1997; Elson et al., 1996b).
Inactivating ATM mutations cause the syndrome ataxia-telangiectasia, which is
characterized by neurodegeneration, cancer predisposition, immunodeficiency,
radiosensitivity, and ocular telangiectasia (Gilad et al., 1996; Savitsky et al., 1995).
Hypomorphic mutations in ATR have been identified in a few individuals with Seckel
syndrome, which is an autosomal recessive condition characterized by low birth weight,
micrognathia, beak-like protrusion of nose, and microcephaly. Mental retardation has
been reported in some cases of Seckel syndrome (O'Driscoll et al., 2003). The
distinctions between the physiologic requirements of ATM and ATR suggest that though
these genes may serve some overlapping roles in DNA damage signaling, each likely
fulfills an individual obligation largely dictated by cell type, proliferation status, and the
form of damage incurred.
It has been shown in Atm-/- mice that newly post-mitotic cells of the developing
brain require Atm for apoptotic induction following IR-induced damage. Lig4-deficiency
results in Atm-dependant apoptosis of post-mitotic neuron populations during
embryogenesis, whereas Xrcc2-/- embryos exhibit Atm-independent apoptosis localized to
proliferating cells in the developing brain (Orii et al., 2006). This difference in Atm
requirement during NHEJ versus during homologous recombination and its non-essential
status during embryogenesis suggest that Atm is not the primary signaling molecule
adapted to the DDR in proliferating neural precursors. Atr is required for embryonic
gastrulation and is involved in maintaining integrity of proliferating tissues in adult mice,
with little or no obvious requirement in largely post-mitotic organs such as the mature
brain (Brown & Baltimore, 2000; Ruzankina et al., 2007). While ATM is typically
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described as responding to double strand breaks, ATR activity is associated with multiple
forms of damage including replication stress-induced DNA damage, UV-induced
pyrimidine dimmers, and base adducts (Cimprich & Cortez, 2008; Mordes et al., 2008).
However, phosphorylation of H2AX on ser 139 is a key characteristic of the DSB
response, which can occur as a result of DNA damage from replication fork collapse.
Recent in vitro studies have shown that replication fork collapse in the absence of ATR
results in H2AX phosphorylation by ATM and DNA-PKcs, and that the accumulation of
Rad51 foci (evidence of homologous recombination) is largely dependant upon H2AX
(Chanoux et al., 2008). These results indicate that ATR-dependent replication fork
stabilization and ATM/DNA-PKcs-mediated H2AX phosphorylation cooperatively
function in response to DSBs generated by replication fork collapse. Thus, despite
distinct physiologic requirements and separate modes of activation, ATM and ATR likely
act synergistically to ensure genomic integrity during all stages of life.
Replication protein A (RPA)-coated stretches of ssDNA are formed during
replication, and are important for localizing ATR to damage sites (Costanzo et al., 2003;
Zou & Elledge, 2003). ATR-interacting protein (ATRIP) is an essential co-factor for
ATR and is required for targeting ATR to RPA-coated ssDNA, to which it directly binds
(Ball et al., 2007; Cortez et al., 2001). Additionally, topoisomerase (DNA) II binding
protein 1 (TopBP1), is involved in activation of the ATR-ATRIP complex through
interactions with both ATRIP and ATR (Kumagai et al., 2006; Mordes et al., 2008). ATR
signaling further depends on the RAD9-RAD1-HUS1 (911) complex that recognizes a
DNA end adjacent to RPA bound ssDNA (Bermudez et al., 2003; Ellison & Stillman,
2003; Zou et al., 2003). ATM activation occurs through a different series of signaling
events involving autophosphorylation and dependence upon the MRN complex
(Bakkenist & Kastan, 2003; Cerosaletti & Concannon, 2004; Cerosaletti et al., 2006;
Kozlov et al., 2006; Lee & Paull, 2004; Lee & Paull, 2005). Figure 3.1 depicts simple
models for the separate activation mechanisms and consequent signaling pathways of
ATM and ATR (Cimprich & Cortez, 2008) In vitro studies using Xenopus egg extracts
and various mammalian cell lines have implicated MRN-dependent ATM activity as an
ATR activator through phosphorylation of TopBP1 in a cell cycle specific manner
(Adams et al., 2006; Cuadrado et al., 2006; Jazayeri et al., 2006; Myers & Cortez, 2006;
Yoo et al., 2007). Alternatively, it has been reported that ATR phosphorylates and
activates ATM in response to UV and replication fork stalling in ATR-Seckel fibroblasts
(Stiff et al., 2006). Thus, while ATR and ATM are thought to have predominantly distinct
signaling mechanisms, there is also evidence of interacting mechanisms in addition to
overlapping substrates between the two kinases. Nonetheless, the interrelationship
between ATR and ATM is complex, and many aspects remain to be elucidated.
Deciphering the relevance of in vitro data to in vivo tissue-specificity of ATR function
remains a challenge as well.
To determine what relationship exists between ATR and ATM signaling in the
nervous system, we used a conditional knock-out strain to inactivate Atr in the nervous
system by breeding it onto a Nestin-cre transgenic line (Brown & Baltimore, 2000).
AtrloxP/loxP; Nestin-cre animals were born at a Mendelian frequency, but showed post-natal
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Figure 3.1 Activation and signaling pathways of ATR and ATM.
(a) The ATR-ATRIP and the 911 complexes are recruited to RPA-coated ssDNA. ATRIP
binds RPA and the 911 clamp is loaded onto the 5’ primer junction with the aid of the
RAD17-RFC2-5 complex. TopBP1 binds and activates ATR in an ATRIP-dependent
manner. ATR is then able to phosphorylate Chk1 and other substrates to mediate origin
firing, cell-cycle arrest, and replication fork stability. (b) DSB formation leads to H2AX
phosphorylation and recruitment of the MRN complex and ATM to the break site. MRN
activity promotes dissociation of the inactive ATM multimer into its monomeric form
through autophosphorylation events. ATM binds to the MRN complex the Nbs1 Cterminus. Binding of MDC1 to "-H2AX results in recruitment of additional ATM-MRN
complexes to the damage site. ATM activity mediates the DSB response through
phosphorylation of substrates such as Chk2. This figure was reprinted by permission
from Macmillan Publisher Ltd: Nature Reviews Molecular Cell Biology Volume 9 No. 8
(Cimprich & Cortez, 2008), copyright 2008, page 617.
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lethality and neurogenesis defects associated with increased apoptosis and reduced
proliferation of neural progenitor cells. Because the cerebellum was most dramatically
affected and is of particular interest in comparing the requirement of ATM with that of
ATR in the nervous system, most emphasis in this study was placed on that region. The
cerebellum arises from the isthmus, which forms the metencephalic-mesencephalic
junction of the neural tube (Hallonet & Le Douarin, 1993; Martinez et al., 1991). Lineage
analysis using chick-quail chimeras revealed contribution of both the mesencephalic and
metencephalic plates to formation of the cerebellar anlage (Hallonet & Le Douarin,
1993). Cerebellar cells originate in the ventricular zone (VZ) and the rhombic lip. The
ventricular zone lining the dorsal region of the fourth ventricle (V4) produces Purkinje
cells (PCs) and interneurons. The rhombic lip arises between the neural tube and the roof
plate of V4; it gives rise to granule cell precursors that migrate over the cerebellar surface
to form the EGL. Cerebellar development is not complete until months after birth in
humans or about P21 in mice (Carletti & Rossi, 2008; Goldowitz & Hamre, 1998; Sillitoe
& Joyner, 2007; Wang & Zoghbi, 2001; Wingate, 2001). PCs exit the cell cycle and
migrate into the cerebellar anlage between E11 and E13 in mice (Edwards et al., 1990;
Miale & Sidman, 1961; Morales & Hatten, 2006). Purkinje cells mediate replication of
the granule cell progenitors in the EGL, as transgenic mice in which Purkinje cells are
ablated at specific developmental times showed reduced mitotic activation of EGL cells
in regions corresponding to PC loss (Smeyne et al., 1995). PCs produce Sonic hedgehog,
which regulates granule cell expansion through its receptor Patched (Goodrich et al.,
1997; Traiffort et al., 1998). Organization of the PCs into the mature monolayer depends
upon proper formation and function of granule cells. This is apparent in Math1-null mice,
in which improper granule cell generation leads to abnormal development of the PC layer
(Ben-Arie et al., 1997). Rhombic lip cells are committed to becoming proliferative EGL
neurons, and undergo final maturation and migration to form the inner granule layer
(IGL) between birth and about P21, by which time proliferation is complete and the EGL
has disappeared (Sillitoe & Joyner, 2007; Wang & Zoghbi, 2001). Figure 3.2
demonstrates gross development of the murine cerebellum from E11 to adulthood
(Goldowitz & Hamre, 1998). Figure 3.3 depicts post-natal development of the
cerebellum, during which granule cells migrate through the Purkinje cell layer (PCL) to
form the mature internal granule cell layer, and the dendritic arborizations fully maturate
and extend their branches to the climbing fibers of the molecular layer (Goldowitz &
Hamre, 1998).
Despite numerous in vitro studies implicating a direct relationship between ATM
and ATR signaling, our genetic analysis of Atm and Atr requirements indicate that these
genes appear to function independently of each other in the CNS. We found that Atr is
required in proliferating cells while as previously reported Atm is critical in post-mitotic
neurons (Herzog et al., 1998; Lee et al., 2001; Ruzankina et al., 2007). Furthermore, we
show that Atr loss induces p53-dependant apoptosis in proliferating neuroprogenitors and
p53-independent cell cycle arrest that results in severe cerebellar dysgenesis, olfactory
bulb malformation, and microcephaly, as well as growth delay and post-natal lethality.
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Figure 3.2 Dramatic changes in cerebellar morphology that occur between
embryogenesis and adulthood.
Sagittal sections of the mouse cerebellum at E11, E13, E15, P0, P7, and adulthood show
the dramatic increase in area and volume (bottom left graph) that occurs between early
specification of the cerebellar anlage and maturation. Filled arrowheads indicate the
neuroepithelium lining the dorsal wall of the fourth ventricle. Open arrowheads indicate
the rhombic lip. Asterisks indicate the primary fissure. The timeline in the upper right
corner illustrates some of the genes that are required for normal cerebellar development
and the ages at which mutations in these genes manifest pathologically. Genes that are
critical to early stages of development are in green. Genes specific to granule cells are
denoted in blue, those specific to Purkinje cells are in red, and those associated with
radial glia are in black. Abbreviations: external granular layer (EGL), Purkinje cell layer
(P), internal granule cell layer (IGL). Reprinted from Trends in Neuroscience, Vol. 21,
No. 9, Dan Goldowitz and Kristin Hamre, The cells and molecules that make a
cerebellum, 375-382, 1998, with permission from Elsevier.
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Figure 3.3 Depiction of post-natal cerebellar development.
At birth, the external granule cell layer is comprised of an outer layer of proliferating
granule cell precursors (blue) and inner layer of newly post-mitotic, differentiating
granule cells (green). Upon exiting the cell cycle, differentiating granule cells migrate
along radial glia fibers (black), through the Purkinje cell layer (red) and into the internal
granule cell layer, where they fully differentiate into mature granule cells (dark green).
Between P7 and P21, the EGL has disappeared and the dendritic arborizations of the
Purkinje cells (PC) have matured into elaborate projections that connect with the
climbing fibers of the molecular layer (ML). Expansion of the granule cells during postnatal development results in an approximately 1000 fold increase in total cerebellar size
between birth and P21 (Goldowitz & Hamre, 1998). Figure is courtesy of Dr. Peter
McKinnon, February 10, 2009.
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3.2

Experimental Procedures
3.2.1

Animals

AtrloxP/loxP were obtained from Dr. Eric J. Brown and crossed onto a Nestin-cre
transgenic line to achieve deletion throughout the nervous system.
To generate a conditional Atm allele, Dr. Peter McKinnon obtained a murine
BAC genomic clone (strain, 129Ola) containing the Atm genomic locus, into which he
inserted a LoxP sequence into a unique BamHI site upstream of the targeted exon and a
floxed NeoTK construct cloned into a XbaI site directly downstream of exon 58 to
generate pAtmloxP. ES cells (W9.5; 129S1/SvImJ) were electroporated with linearized
pAtmLoxP and selected with G418 antibiotic. Correctly targeted cells were identified by
southern blot analysis (Dr. Helen Russell). Targeted ES clones were then electroporated
with pMC-cre, followed by selection in FIAU (5-iodo-2'-fluoro-2'deoxy-1arabinofuranosyluracil) to kill cells containing TK. ES cells were then injected into
blastocysts and the resultant chimeric mice assessed for germline transmission of the
floxed Atm allele (St. Jude Children’s Research Hospital Transgenic Core). Nestin-cre
mice (B6.Cg-Tg(Nes-cre)1Kln/J; JAX #003771) were used to delete Atm throughout the
nervous system.
Animals were housed in an Association for the Assessment and Accreditation of
Laboratory Animal Care (AAALAC)-accredited facility and were maintained in
accordance with the NIH Guide for the Care and Use of Laboratory Animals. The St.
Jude Children’s Research Hospital IACUC approved all procedures for animal use.

3.2.2

Real-time PCR

Genomic DNA was phenol/chloroform extracted from frozen sections and
suspended in TE buffer. DNA concentration was determined from the A260 as measured
using an Ultrospec 2000 UV/Visible Spectrophotometer (Pharmacia Biotech). Standard
DNA was serially diluted at 1:5 from a starting concentration of 100#g/µL. Unknown
samples were diluted to 100#g/µL, such that each reaction contained an equal amount of
DNA. $ DNA was added to iQ™ SYBR® Green supermix (BioRad) containing forward
and reverse primers for either the targeted exon 44 of Atr/58 of Atm or the control exon
29 of Atr/52 of Atm. PCR reaction was carried out using the iQ™5 Multicolor Real-Time
PCR Detection System (BioRad). Measurement numbers were automatically assigned
based on SYBR green amounts fit to a standard curve. The amount of the targeted exon
product was normalized to that of the control exon for each sample.
Atr exon 29 forward primer: 5’ ACTCTGGCTGTAGCGTCCTTTC
Atr exon 29 reverse primer: 5’ TGCTTCTTTTCTGTAATAAATGACTCAAA
Atr exon 44 forward primer: 5’ GAAAGGAGCTTCGCCAGTGT
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Atr exon 44 reverse primer: 5’ GGGCAGGAGTAATTCTTGGAATAC
Atm exon 52 forward primer: 5’ ATGGAATGAAGATTTCATCCTATAAGTTT
Atm exon 52 reverse primer: 5’ ATCCTAGGCCTCCCGTCATTT
Atm exon 58 forward primer: 5’ TCAGCGAAGCGGTGTTCTC
Atm exon 58 reverse primer: 5’ TCATTTGGCCTGTATCTTCTATGTG

3.2.3

Histology and immunohistochemistry

Pregnant female mice were euthanized through cervical dislocation and embryos
were drop-fixed in 4% PFA either overnight or 2-3 days depending upon age. Post-natal
day 5 mice were sacrificed via transcardial perfusion using 4% PFA. Tissues were further
fixed in 4% PFA overnight, and either cryoprotected in 25% PBS-buffered sucrose
solution and embedded in O.C.T. (Tissue-Tek). Frozen tissue was sectioned at 10 µm
thickness using a Microm HM500 M cryostat.
Antigen retrieval was used for all immunohistochemistry using the anti-phospho"H2AX (1:50; Cell Signaling), anti-53BP1 polyclonal (1:500; Bethyl laboratories), antip53 (CM5; 1:500; Vector Laboratories), anti-p53 phospho-Ser-15 (1:500; Cell
Signaling), anti-active caspase 3 (1:500; BD Biosciences), anti-PCNA (1:500; Santa
Cruz) and anti-Ki67 (1:1000; Vector Laboratories) antibodies. Antigen retrieval was not
necessary for labeling with anti-Sox2 (1:1000; Chemicon) or anti-ssDNA (1:300;
Chemicon). Immunostaining against anti-$ tubulin III TUJ1 (1:500; Babco) was equally
efficient with or without antigen retrieval. For immunofluorescent staining, sections were
subsequently immunolabelled with Cy3-conjugated goat anti-mouse (1:400; Jackson
Immunoresearch) or FITC-conjugated goat anti-rabbit secondary antibodies (1:500;
Jackson Immunoresearch) and mounted with Vectashield anti-fade reagent containing
DAPI (Vectorlabs).
Immunohistochemistry for activated caspase-3 or p53-ser15 (murine homologue
is serine 18) was performed overnight at room temperature after quenching endogenous
peroxidase activity with 0.6% hydrogen peroxide in methanol. Immunoreactivity was
visualized with a vasoactive intestinal peptide substrate kit (V.I.P.; Vector Labs)
according to the manufacturer's directions after tissues were treated with biotinylated
secondary antibody and avidin DH-biotinylated horseradish peroxidase-H complex
(Vectastain Elite kit; Vector Labs). Sections were counterstained with 0.1% methyl green
(Vector Labs), dehydrated, and mounted in DPX reagent. Nissl staining was performed
after cryosections were allowed to dry at room temperature and was followed by
dehydration in alcohol and xylene. Apoptotic cells were detected with ApopTag
Fluorescein in situ apoptosis detection kit (Chemicon international) according to the
manufacturer’s instructions. Quantitation of TUNEL, caspase-3, p53-ser15, ssDNA, or
SOX2 positive cells was determined by counting positive signal from images equivalent
in size and magnification between genotypes. Images were captured using an Axioskop
2.0 microscope (Carl Zeiss) and a SPOT camera (Diagnostic Instruments, Inc).
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3.3

Results
3.3.1

Atr deficiency results in microcephaly and cerebellar
dysgenesis

In order to evaluate the specific role of ATR during neurogenesis, AtrloxP/loxP mice
were crossed onto the same Nestin-cre transgenic line used with the Lig4loxP/loxP mice
reported in Chapter 2. Atr+/loxP; Nestin-cre mice were healthy and identical to Atr+/+;
Nestin-cre counterparts. Thus either Atr+/+; Nestin-cre or Atr+/loxP; Nestin-cre genotypes
were used interchangeably as controls and will be referred to collectively as AtrCtrl for
simplicity. AtrloxP/loxP mice were also compared with Atr+/+; Nestin-cre or Atr+/loxP;
Nestin-cre animals. Nestin-cre status had no noticeable effect upon Atr+/+ mice, in
contrast to the report that Nestin-Cre expression can cause neurogenesis defects when
highly expressed in neural progenitor cells (Forni et al., 2006). When Nestin-cre positive
controls were not available, Atr+/+, Atr+/loxP, or AtrloxP/loxP animals were used as controls
as well. Preference was always given to mice containing the Nestin-cre transgenes, when
available. Real-time PCR was used to gauge efficiency of excision of the floxed exon 44
in E13.5 AtrNes-cre CNS compared to Atr+/+; Nestin-cre littermates. DNA extracted from
the whole CNS of 3 separate AtrNes-cre embryos showed 60-80% deletion efficiency
(Figure 3.4). In situ hybridization is currently underway to specifically determine which
areas of the CNS do and do not express an Atr mRNA transcript.
AtrNes-cre animals were born at a frequency consistent with expected Mendelian
ratios (data not shown), but died during early post-natal life. Typically AtrNes-cre animals
did not survive beyond P7, however there were occasional animals that survived up to
P10 or P11. (Two such mice were examined histologically and found to have a less
severe phenotype than that of the typical AtrNes-cre animals described below. Presumably
such older animals were expressing the Nestin-cre transgene at a lower than usual level.)
Cause of death remains undetermined, but is suspected to be associated with malnutrition,
possibly due to inability to efficiently swallow and retain milk.
AtrNes-cre pups showed severe overall growth deficiency and had consistently
smaller brains compared to littermate controls (Figure 3.5A-B). We attribute the small
body size of AtrNes-cre animals, at least partially, to malnutrition based upon our
observation that their stomachs did not contain milk, which was visible in control
littermates. To determine if larger littermates were out-competing the AtrNes-cre animals,
littermates were removed from the cage leaving only the AtrNes-cre pups with the mother.
This had no effect upon feeding or survival. Attempts were also made to hand feed the
animals using canine milk replacement formula. We chose canine formula as the dietary
habits of dogs and mice seemed more similar than that of cats and mice; however we do
not know if feline formula would have been more suitable. One mL syringes were used in
our attempts to hand feed the AtrNes-cre pups. This endeavor was a failure, as the formula
was immediately regurgitated. Thus we speculate that dysphagia contributed to
malnourishment and ultimate lethality of post-natal AtrNes-cre mice.
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Figure 3.4 Nestin-cre mediated deletion efficiency of floxed Atr region in E13.5
AtrNes-cre CNS.
Real-time PCR was used to ascertain deletion efficiency of exon 44 in the AtrNes-cre E13.5
CNS. Results for exon 44 were normalized to those for exon 29.
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Figure 3.5 AtrNes-cre mice showed severe growth defects accompanied by
microcephaly and neurogenesis defects.
(A) P6 AtrCtrl and AtrNes-cre littermates show significant size difference, with AtrNes-cre
animals being ~50% smaller than controls. (B) AtrNes-cre and AtrCtrl brains were collected
from P6 littermates. AtrNes-cre mice have significantly smaller brains than AtrCtrl mice. (C)
Nissl stained sections revealed structural abnormalities in the AtrNes-cre olfactory bulb
(OB), corpus callosum (CC), rostral migratory stream (RMS), and cerebellum (Cer) in
comparison to AtrCtrl (a-b). Immunostaining against calbindin D28K revealed disruption
of Purkinje cell layer (PCL) and decreased cellular density of the internal granule layer
(IGL) in AtrNes-cre animals (c,d). Magnification of Nissl stained panels is 15x.
Magnification of calbindin-stained sections is 100x.
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The cerebellum was most dramatically affected by Atr loss as manifested by lack
of foliation and mislocalization of calbindin-positive Purkinje cells (Figure 3.5C c-d),
consistent with defective granule cell generation as described in other mouse models and
reminiscent of the phenotype described in the Nbnf6/f6; Nestin-cre mouse in which Nbs1 is
conditionally deleted (Ben-Arie et al., 1997; Frappart et al., 2005; Jensen et al., 2002).
Nissl staining revealed structural abnormalities in the forebrain of AtrNes-cre pups as well.
Most notably, decreased cellularity of the corpus callosum was frequently observed and
the rostral migratory stream (RMS) seemed largely nonexistent in sagittal sections
(Figure 3.5C a-b). The RMS is comprised of progenitor cells that originate in the dorsal
wall of the lateral ventricle, commonly referred to as the ventricular zone (VZ), and
possibly in the ganglionic eminence (GE), then migrate to the olfactory bulb where they
mature into inhibitory interneurons (Corbin et al., 2008; Lledo et al., 2008). Nissl stain
was used on coronal sections of P5 AtrCtrl and AtrNes-cre olfactory bulb to confirm loss of
the proliferating cells that comprise the RMS and resultant structural malformation. The
olfactory bulb is a layered structure comprised of different cells types. In AtrNes-cre pups,
the glomerular layer (GL), the external plexiform layer (EPL), and the mitral cell layer
(MCL) appeared largely normal though cellularity seemed decreased. However, the
internal plexiform layer (IPL) and granule cell layer (GCL) were rather undeveloped
(Figure 3.6 upper panels). Consistent with the sparse population of the IPL and GCL,
the RMS was nearly non-existent at age P5 in the AtrNes-cre animals (Figure 3.6 lower
panels). Cellularity appeared drastically decreased throughout the cerebral cortex (CTX)
and the corpus callosum (CC) as well (Figure 3.7).

3.3.2 Atr loss was associated with increased DNA damage and p53dependent apoptosis in the developing brain
Beginning at E13.5, DNA damage, as assessed by immunostaining against "H2AX, was apparent in the EGL and GE. This was not a surprising finding, as we
predicted damage would be sustained in proliferating cells and lead to cell cycle arrest
and/or apoptosis, based upon the report that ATR loss leads to H2AX phosphorylation
upon replication stalling in MEFs (Brown & Baltimore, 2003). The surprising finding
was that "-H2AX foci were not uniformly present in all proliferating areas of the AtrNes-cre
brain. At E13.5, the EGL contained a subset of cells that were positive for "-H2AX,
whereas the RL did not exhibit signs of DNA damage though it is comprised of
proliferating cells. Indeed it was not until E16.5 that any "-H2AX was detected in the RL
of AtrNes-cre mice (Figure 3.8).
The GE also exhibited substantial damage by E13.5 based upon immunostaining
against "-H2AX (data not shown). Between E13.5 and E17.5, the level of damage in the
GE increases with a peak around E16.5/E17.5 and a trough at E18.5 (Figure 3.9). The
GE provides inhibitory interneurons to the cortex, the olfactory bulb via the RMS, and
the striatum. Different subtypes of inhibitory interneurons arise from spatially distinct
progenitor cell populations of the ganglionic eminence (Corbin et al., 2008; Wonders &
Anderson, 2005). The medial ganglionic eminence appears to be the main source of
somatostatin-positive interneurons and of parvalbumin-positive cortical interneurons.
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Figure 3.6 Nissl stained coronal sections of the P5 AtrNes-cre olfactory bulb and rostral
migratory stream.
Coronal sections of the olfactory bulb (upper panels) and the rostro-ventral forebrain
(lower panels) revealed severe depletion of the rostral migratory stream (RMS) and
decreased cellularity in the internal plexiform layer (IPL) and granule cell layer (GCL) of
the AtrNes-cre mice (right) in comparison to controls (left). The mitral cell layer (MCL) and
the external plexiform layer (EPL) appeared similar to those of the AtrCtrl samples though
the glomerular layer (GL) seems sparse in AtrNes-cre samples. Magnification is 100x.
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Figure 3.7 P5 AtrNes-cre forebrain stained for Nissl substance.
Sagittal sections prepared from P5 AtrCtrl and AtrNes-cre brain samples were stained with
Nissl. Though cellularity appears decreased in most regions, overall structure is largely
preserved in the AtrNes-cre samples. The corpus callosum (CC) showed dramatically
decreased cellularity. Sections progress lateral to medial from top to bottom. Other
abbreviations: cortex (CTX), globus pallidus (GP), caudate putamen (CP). Magnification
is 100x.
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Figure 3.8 Pattern of "-H2AX foci in the AtrNes-cre cerebellum.
(A-B) E13.5 AtrNes-cre samples showed increased immunostaining against "-H2AX (red)
in the external granule cell layer (EGL) compared to AtrCtrl littermates, but not in other
regions of the developing cerebellum. (C-D) At E15.5, there was no substantial indication
of DNA damage in the rhombic lip (RL) of AtrNes-cre samples in comparison to controls,
but some damage had arisen in the internal granule cell layer (IGL). (E-F) At E16.5, the
RL showed increased "-H2AX signal and the IGL had sustained more damage than at
E15.5 in AtrNes-cre samples. AtrCtrl samples did not show appreciable "-H2AX signal at
any stage (A, C, E). N is at least 2 for each genotype at each embryonic stage.
Magnification is 200x. Nuclei were stained with DAPI (blue).
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Figure 3.9 Pattern of "-H2AX in the ganglionic eminence and lateral ventricular
zone of embryonic AtrNes-cre mice.
(A,B) At E15.5, the ganglionic eminence (GE) showed substantial "-H2AX (red) signal.
AtrNes-cre animals did not show DNA damage in the cortical ventricular zone (VZ) until
E16.5 (C,D) and by E18.5 "-H2AX was shown throughout the entire cortical VZ and the
outer $ tubulin III (TUJ1) (green) negative region of the GE (E,F). Magnification is 200x.
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Production of calretinin-positive interneurons has been attributed to the caudal ganglionic
eminence, while the lateral ganglionic eminence generates specific subclasses of
interneurons in the striatum, olfactory bulb, piriform cortex, and amygdala (Corbin et al.,
2008). For the sake of simplicity, the GE will be considered as a whole with no emphasis
placed upon its divisions in this study. However, subsequent work will be required to
determine if loss of Atr in the GE specifically affects the subtypes of interneurons in the
forebrain.
The proliferative dorsal wall of the lateral ventricle gives rise to a vast variety of
neural precursors that will produce the excitatory projection neurons of the cerebral
cortex (Corbin et al., 2008). We predicted that the AtrNes-cre animals would begin to show
severe damage in the VZ relatively early during embryogenesis, similar to that seen in the
EGL at E13.5. However, it was not until E16.5 that significant damage was detected in
the dorsal VZ (Figure 3.9 and 3.10). In line with the presence of DNA damage and
defective neurogenesis, apoptosis was found to be a prominent occurrence during
neurogenesis in AtrNes-cre samples. The pattern of cell death was somewhat similar to that
of "-H2AX foci. Despite the presence of "-H2AX and 53BP1 foci in the E13.5 AtrNes-cre
EGL, apoptosis was not detected using either TUNEL assay or immunostaining against
ssDNA in the E13.5 cerebellum (data not shown). The AtrNes-cre GE did contain many
apoptotic cells, as predicted by the presence of substantial DNA damage in that area at
E13.5 (data not shown).
The presence of "-H2AX is not necessarily an indicator of apoptosis, as
demonstrated by the occurrence of DNA damage foci in the adult Lig4Nes-cre which did
not exhibit apoptosis based upon TUNEL assay (data not shown). However, DNA
damage does lead to apoptosis such that the two phenomena are often correlated.
Immunostaining against ssDNA (data not shown) and TUNEL assay demonstrated this in
AtrCtrl and AtrNes-cre in which apoptosis did largely mirror the pattern of "-H2AX observed
at E15.5 and onward. In the E15.5 AtrNes-cre cerebellum, most cell death was observed in
the EGL with some TUNEL-positive cells in the RL (Figure 3.11 upper panels). The
level of cell death increased in the E16.5 cerebellum compared to that of the E15.5 AtrNescre
samples (Figure 3.11 middle panels). By E18.5, cell death was seen primarily in the
IGL of the AtrNes-cre cerebellum (Figure 3.11 lower panels). This pattern of cell death
was relatively consistent with the pattern of DNA damage foci described above. At
E18.5, the AtrNes-cre cerebellum showed "-H2AX signal only in the IGL, similar to the
pattern of cell death (data not shown). The same proved true of the GE and VZ in that the
occurrence of apoptosis largely correlated with the presence of DNA damage (Figure
3.12 and 3.13).
After DNA damage, both ATM and ATR phosphorylate p53 on serine 15 (serine
18 in mice) (Canman et al., 1998; Cimprich & Cortez, 2008; Tibbetts et al., 1999). As a
critical part of the DNA damage response, p53 can activate either cell cycle arrest or
apoptosis (Vousden & Lu, 2002). In order to better understand the nature of apoptotic
induction in AtrNes-cre mice, immunostaining against p53-phosphoserine 15 was used.
Phosphorylation of p53-serine 15 was detected in the cerebellum, GE and cortical
ventricular zone (Figure 3.14) and mimicked the patterns of apoptosis and DNA damage
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Figure 3.10 Pattern of "-H2AX formation in the developing AtrNes-cre cortex.
(A, B)The ventricular zone of the AtrNes-cre neopallial cortex showed only a slight increase
in "-H2AX (red) immunostaining as compared to AtrCtrl at E15.5. (C-F) From E16.5 to
E18.5, DNA damage became much more prominent in this region. Labeling against $
tubulin III (TUJ1) (green) delineated the border between the VZ and the more
differentiated sub-ventricular zone. Magnification is 200x.

53

Figure 3.11 Pattern of cell death in the AtrNes-cre cerebellum.
TUNEL labeling (green) was used to detect apoptosis in the embryonic AtrNes-cre
cerebellum. At E15.5, AtrNes-cre samples showed increased apoptosis primarily in the
external granule layer (EGL). Cell death was also apparent in the rhombic lip (RL) in
E15.5 AtrNes-cre samples (upper panels). E16.5 AtrNes-cre samples showed greater presence
of cell death in all regions of the cerebellum, except the dorsal wall of the fourth ventricle
(VZ) (middle panels). At E18.5, the RL is diminished and the EGL is fully formed.
Lower panels show anterior cerebella of E18.5 AtrCtrl (left) and AtrNes-cre (right).
Apoptosis is mainly visible in the IGL. Magnification is 200x. Nuclei were stained with
propidium iodide (red). Arrows indicate TUNEL-positive cells.
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Figure 3.12 Pattern of cell death in lateral ventricular zone and ganglionic eminence
of AtrNes-cre embryos.
At E15.5, the ganglionic eminence (GE) showed substantial TUNEL signal (green)
(upper panels). AtrNes-cre animals did not show substantial cell death in the cortical
ventricular zone (VZ) until E16.5 (middle panels) and by E18.5 TUNEL positive cells
were visible throughout the entire cortical VZ and the outer region of the GE (lower
panels). Magnification is 200x. Nuclei were stained with propidium iodide (red). Lateral
ventricle is abbreviated LV.
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Figure 3.13 Pattern of cell death in the ventricular zone of the embryonic AtrNes-cre
cortex.
The ventricular zone of the AtrNes-cre neopallial cortex showed only a slight increase in
TUNEL signal (green) as compared to AtrCtrl at E15.5 (upper panels). From E16.5 to
E18.5, DNA damage became much more prominent in this region (middle and lower
panels). Magnification is 200x. Nuclei were stained with propidium iodide (red).
Abbreviations: ventricular zone (VZ), sub-ventricular zone (SVZ), intermediate zone
(IZ), cortical plate (CP).
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Figure 3.14 Immunostaining against p53-phosphoserine 18 in E16.5 AtrCtrl and
AtrNes-cre samples.
Activation of p53 correlated with the incidence of "-H2AX appearance and apoptosis. (A,
B) At E16.5, the AtrNes-cre external granule layer (EGL) and rhombic lip (RL) showed upregulation of p53 that was not observed in AtrCtrl animals. (C-F) The same was true in the
ganglionic eminence (GE) and the ventricular zone (VZ). The intermediate zone (IZ) and
the cortical plate (CP) were negative for p53 induction. Arrows indicate p53 ser 18positive cells.
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observed during development of AtrNes-cre embryos (Figures 3.8-3.13). AtrNes-cre mice
were crossed onto a p53-null background to determine if p53 induction caused
microcephaly associated with ATR-Seckel syndrome (Personal communication with Dr.
Pierre-Olivier Frappart, March 6, 2008). Dr. Frappart observed full rescue of apoptosis in
all affected regions of the AtrNes-cre E15.5 animals in the p53-/- genetic background, based
upon TUNEL labeling and immunostaining against active caspase-3 (Figure 3.15Ca-f,
m-r). However, P5 AtrNes-crep53-/- animals did not exhibit substantial rescue of
neuropathology associated with Atr loss (Figure 3.15A-B). Furthermore, Dr. Frappart’s
data showed no defect in proliferation of granule cell progenitors in the E15.5 AtrNes-cre or
AtrNes-cre p53-/- EGL as indicated by BrdU labeling of S-phase cells (Figure 3.15Cs-u).
The same was true for the GE (Figure 3.15Cv-x). These data indicate that though p53dependent apoptosis is a feature of the AtrNes-cre phenotype, it does not significantly
contribute to the gross pathological state of the brain. Furthermore, p53-induced cell
cycle arrest is not a significant contributing factor to the microcephaly and aberrant
neurogenesis that is characteristic of the AtrNes-cre genotype and hence ATR-SS. These
results are currently being independently confirmed.

3.3.3 Atr deficiency results in depletion of proliferating cell
populations during neurogenesis
Having established the neurogenic defects that result from Atr deficiency in the
AtrNes-cre model were not due to p53 signaling, embryonic studies were necessary to
determine the events responsible for the phenotype. It was clear based upon Dr.
Frappart’s report of the AtrNes-cre p53-/- mice that apoptosis as detected by TUNEL and
active-caspase 3 was not the cause of defective neurogenesis, as p53-deficiency rescued
apoptosis without correcting neural malformations. Up to E15.5, no proliferation defect
was observed in any area of the AtrNes-cre CNS when compared to controls (Figure 3.15C
and data not shown). At E16.5 however, a dramatic decrease in PCNA and Ki67 positive
cells was apparent in the EGL. The rhombic lip did not appear significantly different in
AtrNes-cre samples as compared to controls (Figure 3.16). It was surprising that the RL
was not more dramatically affected by Atr inactivation, as it is comprised of proliferating
neural precursors. To determine if the AtrNes-cre genotype affected the proliferating neural
precursors of the RL and the fourth ventricle (V4), immunostaining against SOX2 was
performed. SOX 2 is a transcription factor required for proliferation and maintenance of
neural stem cells (Nicolis, 2007; Zappone et al., 2000). The RL remains prominent until
about E17.5, at which time the EGL appears highly developed and the RL is largely
diminished. Despite the presence of "-H2AX and apoptotic cells in the E16.5 AtrNes-cre
RL, there was no decrease in the number of either SOX2-positive or PCNA- positive
cells (Figure 3.16-3.17). No notable differences in either SOX2 expression or expression
of the proliferation markers PCNA and Ki67 were observed in the forebrain until later
stages of embryonic development. Proliferation of the lateral ventricular zone and RMS
appeared largely unaffected in E16.5 and E17.5 AtrNes-cre samples (data not shown). At
E18.5 there was a drastic difference in PCNA status between AtrCtrl and AtrNes-cre
ganglionic eminence (GE) and the lateral ventricular zone (Figure 3.18A-E). A more
subtle decrease in the number of proliferating cells in the OB was observed (Figure
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Figure 3.15 Apoptosis was rescued in AtrNes-cre p53-/- animals, but neuropathology
was not affected by p53 loss in P5 AtrNes-cre mice.
(A) AtrNes-cre p53+/- mice showed significantly increased weight in comparison to agematched AtrNes-cre littermates (P value = 0.0063). The AtrNes-cre p53-/- genotype also
positively affected AtrNes-cre body weight (P value = 0.0099). Neither the AtrNes-cre p53+/nor AtrNes-cre p53-/- genotype showed a significant difference in brain size compared with
age-matched AtrNes-cre littermates (P values are 0.0730 and 0.1631, respectively). (B) The
AtrNes-cre p53-/- phenotype was indistinguishable from that of AtrNes-cre in terms of size (ac) or fine structure of the brain based on H&E stain (d-i) or immunostaining against
calbindin D18K to label cerebellar Purkinje cells (j-o). (C) Sections were collected from
E15.5 embryos and evaluated for differences in DNA damage signaling between the
AtrNes-cre and AtrNes-cre p53-/- samples. The p53-/- background rescued apoptosis based on
TUNEL labeling (a-f) and immunostaining against active-caspase 3 (m-r).
Immunostaining against "-H2AX showed persistent DNA damage in AtrNes-cre p53-/embryos (g-l). BrdU labeling revealed no impact of either the AtrNes-cre or AtrNes-cre p53-/upon proliferation at E15.5 (s-x). Immunostaining against p53 confirmed its stabilization
in AtrNes-cre samples and showed its inactivation in AtrNes-cre p53-/- samples (y-&). Personal
communication with Dr. Pierre-Olivier Frappart, March 6, 2008.
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Figure 3.16 Proliferation of the EGL in the E16.5 AtrNes-cre cerebellum is decreased.
(A) Immunostaining against PCNA (upper panels) and Ki67 (lower panels) was used to
assess the number of proliferating cells in the E16.5 AtrCtrl (left) and AtrNes-cre (right)
cerebella. (B) The total number of PCNA-positive cells was counted from images
representative of those shown in A. (C) The total number of Ki67-positive cells was
counted from images representative of those shown in A. Multiple sections from each
sample were analyzed. Three animals per genotype were analyzed. P value was derived
from an unpaired t-test. Photomicrographs were captured at 200x magnification.
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Figure 3.17 The rhombic lip is largely unaffected in AtrNes-cre embryos.
Immunostaining against SOX2 (red) and $ tubulin III (TUJ1) (green) was used to
analyzed the effects of the AtrNes-cre genotype on cerebellar precursor cells in E15.5 (A,B)
and E16.5 (E, F) samples. Immunostaining of E15.5 AtrCtrl and AtrNes-cre samples against
PCNA (green) indicated no difference in proliferation in the RL at this stage (C, D).
Similarly, there was no change in the number of PCNA-positive cells (red) in the RL of
AtrCtrl and AtrNes-cre samples at E16.5 (G, H). Quantitation of these results (as described in
Figure 3.14) was performed for E16.5 samples (right hand panels). Photomicrographs
were captured at 200x magnification.
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Figure 3.18 Immunostaining against PCNA in E18.5 AtrNes-cre forebrain.
Immunostaining against PCNA (red) showed decreased proliferation in the AtrNes-cre
forebrain at E18.5. Proliferating regions such as the ganglionic eminence (GE), the walls
of the lateral ventricle (VZ), the subventricular zone (SVZ) and the rostral migratory
stream of the olfactory bulb (OB) were affected. Nuclei were stained with DAPI (blue).
Magnification is 200x. The lateral ventricle is abbreviated LV.
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3.18E-F). Immunostaining against Ki67 was consistent with those findings (data not
shown). Immunostaining against PCNA revealed substantial depletion of proliferating
cells in the lateral ventricular zone of P5 AtrNes-cre animals, in comparison to littermate
controls (Figure 3.19A-B). The AtrNes-cre cerebellar EGL also had significantly fewer
proliferating cells during post-natal life, consistent with the embryonic findings. This was
particularly true in more lateral sections (Figure 3.19C-D) and less dramatic (though
obvious compared to AtrCtrl) in medial regions that displayed a relatively thicker EGL
with more proliferating cells (Figure 3.19E-F). The AtrNes-cre dentate gyrus showed only
a marginal decrease in PCNA positive cells compared to that of AtrCtrl mice (data not
shown). We therefore attribute the neurogenesis defects found in AtrNes-cre to reduced
proliferation, rather than apoptosis, in the developing nervous system.

3.3.4 Atm and Atm functions are not obviously redundant in the
developing brain
The induction of p53-dependant cell death in proliferating regions of the AtrNes-cre
embryonic brain indicated that either ATR signaling is not required for p53 activity in
these regions or that ATM is responsible for p53 activation in proliferating neural
precursors in the absence of ATR. Alternatively there may be another gene involved in
p53 regulation during the DNA damage response.
To genetically delineate the in vivo distinctions between ATM and ATR activity
during neurogenesis, Atm was conditionally deleted in the CNS through generation of
AtmloxP/loxP mice which were then crossed with Atr+/loxP; Nestin-cre mice to produce
AtrloxP/loxP; AtmloxP/loxP; Nestin-cre (AtrNes-cre AtmNes- cre) double conditional knock-out
animals. The conditional Atm allele was chosen for this study in order to circumvent
possible affects outside the nervous system as well as to promote more efficient breeding
strategies (germline Atm-/- animals are sterile). AtmNes-cre mice had not been previously
characterized, thus it was necessary to first confirm the ablation of Atm activity in the
nervous system. At the time these animals were generated, there was not a reliable
antibody against ATM suitable for use in murine tissue. So, we used real-time PCR to
confirm excision of the DNA encoding the targeted exon and assessed the effects of the
AtmNes-cre genotype on IR-induced apoptosis in the post-natal cerebellum. DNA extracted
from cryosections of E15.5 AtrNes-cre AtmNes-cre brains was used for real-time PCR analysis
of excision efficiency for exon 58, which is the floxed exon of the Atm conditional
mouse model used in this study. In comparison to one Atr+/loxP Atm+/loxP; Nestin-cre
(Atr+/Nes-cre Atm+/Nes-cre) three AtrNes-cre AtmNes-cre showed approximately 70-80% deletion
efficiency (Figure 3.20A). To confirm adequate decrease of Atm activity, P6 AtmCtrl and
AtmNes-cre animals were subjected to 18 Gy IR and allowed to recover for 18 hours prior
to sacrifice. TUNEL assay revealed abrogated apoptosis in the EGL and dentate gyrus
(data not shown) of the AtmNes-cre animals (Figure 3.20B). Untreated AtrCtrl AtmNes-cre
samples were identical to untreated AtrCtrl AtmCtrl littermates in every aspect analyzed.
AtrCtrl AtmNes-cre controls have been excluded from some figures for more efficient use of
space.
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Figure 3.19 Immunostaining against PCNA in P5 AtrCtrl and AtrNes-cre sagittal sections
of cerebellum and forebrain.
Immunostaining against PCNA (red) was applied to brain sections collected from AtrCtrl
and AtrNes-cre mice at P5. Similar to results obtained at E18.5 (Figure 3.16), the walls of
the lateral ventricle showed drastically decreased PCNA positivity in the developing
cortex and basal ganglia of AtrNes-cre samples (A, B). The EGL of the lateral cerebellum
was nearly non-existent and showed almost no PCNA-positive cells in the AtrNes-cre
samples, in stark contrast to that of age-matched AtrCtrl animals (C, D). The EGL of the
medial cerebellum was thicker than in the lateral sections, but still showed decreased
presence of PCNA-positive cells compared to controls (E, F). Nuclei were stained with
DAPI (blue). Magnification is 200x in panels A and B, 100x in C-F.
65

Figure 3.20 Efficient Nestin-cre mediated excision of Atm exon 58 and confirmation
of genotype consistent with Atm-/- mice.
(A) Real-time PCR was used to ascertain deletion efficiency of exon 58 in the AtmNes-cre
E15.5 CNS. Results for exon 58 were normalized to those for exon 52. (B) P6 AtmCtrl and
AtmNes-cre mice were treated with 18 Gy of IR or mock irradiated and allowed a recovery
period of 18 hours. TUNEL assay (green) and immunostaining against $ tubulin III
(TUJ1) (red) were performed. Nuclei were stained with DAPI (blue). Magnification is
200x.
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AtrNes-cre AtmNes-cre mice were born at the expected Mendelian ratio (data not
shown), and were phenotypically indistinguishable from AtrNes-cre littermates (Figure
3.21). No difference was observed in either the gross appearance or histological features
between the AtrNes-creAtmCtrl and AtrNes-cre AtmNes-cre brains (Figure 3.21A). Neither brain
nor body weights showed any significant difference (Figure 3.21B). Lifespan and
capacity to feed properly were similarly unaffected in AtrNes-cre AtmNes-cre pups compared
to AtrNes-cre AtmCtrl littermates (data not shown). Immunostaining against calbindin-D28K
showed the cerebellar abnormalities typical of AtrNes-cre mice to be unaffected by Atmdeficiency (Figure 3.21C). Other morphologic abnormalities described in section 3.3.1
for AtrNes-cre mice were identical to those found in AtrNes-cre AtmNes-cre animals (data not
shown). We compared the endogenous DNA damage response between AtrNes-cre AtmCtrl
and AtrNes-cre AtmNes-cre littermates as well. Immunostaining against total p53 revealed its
stabilization in the E16.5 EGL of both AtrNes-cre AtmCtrl and AtrNes-cre AtmNes-cre samples,
while no p53-positive cells were observed in AtrCtrl AtmCtrl and AtrCtrl AtmNes-cre samples
(Figure 3.22A-C and data not shown). Phosphorylation of p53 on serine 18 observed in
the EGL of AtrNes-cre AtmCtrl embryos was entirely abrogated by Atm-deficiency (Figure
3.22D-F). This leads us to speculate that the p53-phosphoserine 18 positive cells
observed in the embryonic EGL of AtrNes-cre mice likely reflect granule precursor cells
that acquired damage during later stages of replication, but did not initiate the DSB
response until after exiting the cell cycle. However, further experiments would be
required to prove this to be the case, rather than Atm induction in replicating neural
precursors. TUNEL assay and immunostaining against Ki67 were used to determine if
Atm loss affected either apoptosis or proliferation in AtrNes-cre embryos. At E16.5, no
significant difference was observed in the levels of either apoptosis or proliferation
between AtrNes-cre AtmCtrl and AtrNes-cre AtmNes-cre animals, as demonstrated in the EGL
(Figure 3.22G-L). Similarly, no differences in proliferation or apoptosis were observed
in the RL, cortex, ganglionic eminence, or other areas in the AtrNes-cre AtmNes-cre nervous
system when compared with age-matched AtrNes-cre AtmCtrl embryos. Phosphorylation of
H2AX on ser 139 was also similar between AtrNes-cre AtmNes-cre and AtrNes-cre AtmCtrl
embryos (data not shown). These data suggest that ATR and ATM do not function
redundantly in the developing nervous system, but may cooperate indirectly to ensure
genomic stability.

3.4

Discussion

ATM and ATR are structurally and functionally similar signaling kinases that
share many overlapping substrates and are involved in the DNA damage response.
However, the physiologic requirements of these genes are quite distinct as ATRdeficiency is associated with developmental microcephaly and ATM inactivation leads to
the neurodegenerative syndrome A-T (Cimprich & Cortez, 2008). Activation of ATR
occurs through recognition of RPA-coated ssDNA regions and interaction with TopBP1
and ATRIP; whereas current knowledge of ATM activation revolves around its being
recruited to DSB sites and undergoing autophosphorylation events that are partially
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Figure 3.21 AtrNes-cre AtmNes-cre mice are indistinguishable from AtrNes-cre littermates.
(A) Measurement of the AtmNes-cre mutation towards AtrNes-Cre brain size. (B) Brain and
body weights were collected from sex-matched cohorts at P5. Error bars represent
standard deviation. P value = 1 between the AtrNes-Cre AtmCtrl brain weights and the AtrNesCre
AtmNes-cre brain weights. P value = 0.09228 (n =3) between the AtrNes-Cre AtmCtrl body
weights and the AtrNes-Cre AtmNes-cre body weights. (C) AtrNes-cre AtmNes-cre cerebellar
morphology was largely similar to that of AtrNes-cre AtmCtrl littermates, as shown by
immunostaining against calbindin-D28K. Methyl green was used to counterstain nuclei.
Magnification is 100x.
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Figure 3.22 DNA damage signaling in the E16.5 AtrNes-cre AtmNes-cre EGL.
(A-C) Immunostaining against p53 (purple) showed similar stabilization of total p53 in
E16.5 AtrNes-cre AtmCtrl compared to AtrNes-cre AtmNes-cr e littermates. (D-E) Phosphorylation
of p53 serine 18 (purple) was largely abrogated in AtrNes-cre AtmNes-cr e samples. (G-I)
TUNEL assay showed that Atm-deficiency did not significantly block apoptosis in the
AtrNes-cre AtmNes-cr e EGL, as cell death was similar to that observed in AtrNes-cre AtmCtrl
samples. (J-I) Immunostaining against Ki67 revealed no effect of Atm-deficiency on
proliferation in the E16.5 EGL. Because cerebellar sections are not matched in this
figure, no conclusions can be drawn regarding structural differences between any of the
genotypes. No differences were observed between AtrCtrl AtmCtrl and AtrCtrlAtmNes-cre
samples (data not shown). Magnification is 200x.
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dependant upon the MRN complex (Mordes & Cortez, 2008; Mordes et al., 2008). For
example, ATM-phosphoserine 1981 foci are largely reduced in Nbs1 mutant cells
(Kitagawa et al., 2004). Phosphorylation of p53 at serine 15 is an integral component of
the DNA damage response. It has been shown that ATM is an important mediator of p53
induction both in vitro and in vivo (Banin et al., 1998; Canman et al., 1998; Kastan et al.,
1992; Khanna et al., 1998; Lavin, 2008). ATR function has also been linked to p53
activity. Doxycycline induced overexpression of catalytically inactive ATR in human
fibroblasts inhibited p53 phosphorylation on serines 15 and 37 (Tibbetts et al., 1999).
Lenti-cre- infected ATRflox/- fibroblasts showed reduced p53-serine 18 phosphorylation at
later time points following IR, with ATM being responsible at earlier time points (Brown
& Baltimore, 2003).
The AtrNes-cre phenotype provided insight into the nature of developmental delay
and microcephaly associated with ATR-Seckel syndrome. Consistent with the known
requirements of ATR in responding to replication stress and UV-induced DNA damage,
DSBs associated with p53-dependant apoptosis were observed in areas of the developing
AtrNes-cre brain that are largely populated by proliferating progenitor cells. Importantly,
Atr-deficiency also led to a significant decrease in the number of proliferating cells in the
forebrain and cerebellar EGL of AtrNes-cre embryos. Surprisingly, this affect was not
observed in the rhombic lip, which is comprised of proliferating progenitor cells that
generate the EGL. Additionally, it was surprising that the forebrain did not show the
decrease in proliferation until E18.5. As the appearance of DSBs, apoptosis, and
decreased number of proliferating progenitor cells coincided temporally, it seems likely
that these effects of Atr loss result directly from DNA damage. The question that arises
though is why it takes so long for that damage to appear anteriorly, and why the
proliferating cells of the rhombic lip are not affected while the EGL shows such a
pronounced defect.
Parallel studies are currently underway in a TopBP1 conditional knock-out in
which the rhombic lip is dramatically affected by E13.5 and there is clear reduction in the
SOX2-positive progenitors of both the rhombic lip and the dorsal wall of V4 that
produces progenitor cells which will generate cells such as cerebellar interneurons. We
hope that through extensive comparison of the TopBP1 mutant and the AtrNes-cre mice, the
relationship between ATR and TopBP1and the specific requirements for ATR activity in
different cell types can be determined. Of course, we cannot neglect the possibility that
Cre activity is less efficient in some cell types of the AtrNes-cre embryos (despite the
phenotype of the TopBP1 mutants crossed with the same Nestin-cre line). There is also
the question as to how long Atr protein produced prior to gene deletion remains stable in
these cell types. There is not currently a suitable antibody against Atr with which we can
directly assess protein expression, so in situ hybridization experiments are underway to
better evaluate these issues. Germline deletion of Atr leads to lethality by E7.5,
suggesting that Atr is depleted within 24 hours after maternal supply is exhausted.
I have shown here that p53 is stabilized in the Atr-deficient nervous system and is
responsible for apoptosis of cells in the EGL and VZ in response to DNA damage
occurring after Atr loss. A subset of cells in the cerebellum and other developing regions
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showed Atm-dependant phosphorylation of p53 serine 18 in AtrNes-cre embryos. Induction
of p53 was correlated with apoptosis in the developing AtrNes-cre brain. In AtrNes-cre AtmNescre
embryos, p53 serine18 phosphorylation was severely attenuated, but apoptosis
occurred at a level consistent with that of AtrNes-cre AtmCtrl samples. Apoptosis observed in
the embryonic AtrNes-cre brain is p53-dependant however, as cell death was significantly
abrogated in AtrNes-cre p53-/- animals. We speculate that the cells exhibiting Atmdependant p53 serine18 phosphorylation had recently exited the cell cycle carrying
damage accrued during replication, which resulted in death. However, experiments (such
as co-labeling with TUNEL and antibodies against cell cycle markers or doublecortin,
which marks post-mitotic, differentiating cells) have not been performed to determine if
this is the case. This data also indicates a mechanism of DNA-damage induced p53
stabilization that is independent of either Atr or Atm. Further work will be necessary to
identify the factor(s) responsible for p53 induction in this situation. Possibilities include
DNA-PKcs, which is another serine/threonine kinase similar to ATR and ATM, but so far
has been characterized primarily as a part of the NHEJ repair process (Mahaney et al.,
2009). The role of DNA-PKcs in the nervous system is unclear.
Though ATR and ATM deficiency result in highly different neuropathologies, the
possibility exists that there are still overlapping, redundant functions in the brain. ATR
has been reported to function upstream of ATM. Fibroblasts derived from an ATR-Seckel
syndrome individual showed defective ATM autophosphorylation on serine 1981 in
response to either hydroxyurea-induced replication stress or UV-induced damage.
Targeting ATR by siRNA was used to show normal ATM serine 1981 phosphorylation in
response to IR (Myers & Cortez, 2006; Stiff et al., 2006). Alternatively, it has also been
reported that ATM and NBS1 are required for full ATR-dependent phosphorylation of
Chk1 during S and G2 phases of the cell cycle and for the formation of RPA-coated
ssDNA, which is required for ATRIP mediated ATR recruitment (Jazayeri et al., 2006).
Additionally, it has been reported that IR-induced Chk1 phosphorylation depends upon
ATR, ATM, and MRE11, but HU and UV-induced Chk1 phosphorylation is ATRdependant and independent of ATM and MRE11. It has been shown also that ATM and
MRE11 are required for formation of RPA-coated ssDNA (Myers & Cortez, 2006).
While we have confirmed that Chk1 phosphorylation is indeed decreased in AtrNes-cre
brains (data not shown), we have not adequately addressed the contribution of Atm to
Chk1 activation in vivo. These studies will be performed in the near future. Thus far, we
have made no attempts to link MRN activity with Atr requirements in the nervous
system. This is a highly compelling idea however, particularly given the similarities
between ATR-Seckel syndrome and NBS. Further evidence of potential in vivo
interactions between Nbs1 and Atr might also be hinted at in the phenotypic similarities
between the conditional Nbs1 knock-out mice and the AtrNes-cre animals (Frappart et al.,
2005).
In essence this study provides important insight into the pathology and etiology of
ATR-Seckel syndrome. Based upon the microcephaly observed in the AtrNes-cre mice, we
can extrapolate that ATR-Seckel syndrome is distinct from LIG4 syndrome in that it
results from a combination of apoptosis and decreased proliferation (LIG4 syndrome
appears to result strictly from apoptosis of newly post-mitotic cells in the developing
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nervous system). The data shown here also indicate that while some Atm activity is
induced in the AtrNes-cre brain (based upon p53 serine18 phosphorylation), Atr and Atm
signaling pathways operate relatively independently in the developing nervous system.
Furthermore, this study also provides a more detailed account of the specificity with
which ATM and ATR are required to monitor genomic integrity during different stages
of the cell cycle.
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CHAPTER 4

DISCUSSION

Human syndromes in which the DNA damage response is defective can result in a
variety of deleterious outcomes ranging from immunodeficiency, cancer predisposition,
and infertility to profound neuropathology in the form of either degeneration or
microcephaly. In particular, DNA damage poses a tremendous threat to the human
nervous system, and when DNA repair mechanisms go awry the structural and functional
integrity of the nervous system is at stake. Some diseases associated with DSB repair
defects include ataxia-telangiectasia, Nijmegen breakage syndrome, ataxia-telangiectasialike disease, LIG4 syndrome, and ATR-Seckel syndrome. Additionally, defective singlestrand break repair mechanisms can also result in neurodegeneration similar to that of AT, but without any extraneural deficiencies. Examples of SSB repair deficiencies include
ataxia with oculomotor apraxia 1 and spinocerebellar ataxia with axonal neuropathy.
Similarly, mutations in components of the nucleotide excision repair pathway have been
associated with the human syndromes xeroderma pigmentosum, Cockayne syndrome,
and trichothiodystrophy, all of which present with varying degrees of neuropathology.
While these conditions share many phenotypic similarities, each has its own distinct
characteristics attributable to the gene and repair pathway affected (McKinnon, 2009).
My work has sought to determine the signaling mechanisms that prevent the neurologic
phenotypes of Nijmegen breakage syndrome, ataxia-telangiectasia, ataxia-telangiectasia
like disease, and ATR-Seckel syndrome.
Atm-dependent apoptosis is necessary for elimination of newly post-mitotic,
genotoxically stressed cells during neurogenesis (Herzog et al., 1998). The MRN
complex is required for efficient ATM activity, and deficiencies in its components Mre11
and Nbs1 result in immunodeficiency and radiation sensitivity similar to that seen in
ATM-deficiency. However, NBS results in microcephaly while A-T and ATLD are
characterized by neurodegeneration (Gatti & Swift, 1985; McKinnon, 2009; Stewart et
al., 1999; van der Burgt et al., 1996). To determine why MRE11 and Nbs1 hypomorphic
mutations result in different neuropathology, we compared the DNA damage response in
the nervous systems of Mre11 and Nbs1 mutant mice with that of Atm-/- mice. The
Mre11ATLD1/ATLD1 and Nbs1!B/!B mutant mice were designed to mimic the hypomorphic
mutations identified in ATLD and NBS individuals, respectively (Theunissen et al., 2003;
Williams et al., 2002). Despite decreased Atm autophosphorylation after DNA damage in
the brains of both models, the Nbs1!B/!B mutants showed an otherwise normal response to
IR and endogenously occurring damage incurred in Nbs1, Lig4 double deficient mice. In
contrast, Mre11ATLD1/ATLD1 mutants showed abrogated Atm-dependent, Chk2 and p53induced apoptosis of early post-mitotic neural cells in response to DSBs, similar to Atm-/animals. We postulate that therein lays the distinction between ATLD and NBS
neuropathology.
Similar to NBS, ATR-Seckel syndrome is characterized by microcephaly, but is
associated with hypomorphic mutations in the ATR kinase (O'Driscoll et al., 2003). ATM
and ATR share structural similarities as well as overlapping substrates, but respond to
different forms of damage and undergo distinct modes of activation (Cimprich & Cortez,
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2008; Mordes & Cortez, 2008). In vitro studies indicate direct cooperation and crosstalk
in both function and interaction between these molecules (Cimprich & Cortez, 2008).
Physiologically it is unclear how relevant these studies are, particularly because the
neurologic consequences of ATM and ATR deficiencies are so distinct. Atr-/- mice die
very early in embryonic development (~E6-7.5), so a conditional Atr knock-out mouse
model (Brown & Baltimore, 2000) was used to compare the requirements for these two
kinases in the nervous system. AtrNes-cre mice were born at a Mendelian ratio, but
typically died within the first week of life. Failure to thrive and severe neurogenesis
defects were deemed to be the cause of death. Decreased proliferative capacity and p53dependant apoptosis caused depletion of the cerebellar EGL and abnormal forebrain
development. These characteristics of the AtrNes-cre animals resemble those described in
ATR-SS individuals, and were due primarily to proliferation failure of neural progenitors
as p53-deficiency rescued apoptosis without dramatically impacting CNS morphology.
Atm-deficiency did not impact the AtrNes-cre phenotype, though it did abrogate
phosphorylation of p53-serine 18. Total p53 stabilization was not affected by Atm-loss
and apoptosis was still detected in AtrNes-cre AtmNes-cre embryos. Thus, we conclude that
while ATR and ATM likely cooperate in maintaining CNS integrity, the two proteins do
not appear to directly interact genetically.
As a whole, this work provides deeper understanding into the requirements of
ATR and the MRN complex in DSB signaling in the nervous system. Prior to these
studies, most knowledge of ATR and MRN behavior was restricted to work using either
primary fibroblasts or immortalized cell lines, neither of which are appropriate indicators
of physiologic conditions in the nervous system. However, the mouse models used here
have their limitations. While inactivating mutations in ATM and Mre11 cause
neurodegeneration in humans, there is no obvious neuropathology in either Atm-/- or
Mre11ATLD1/ATLD1 mice. Similarly, Nbs1!B/!B mice do not exhibit striking microcephaly
though there is a minor, but statistically significant reduction in brain size. While the
Atm, Mre11, and Nbs1 mutants used were designed to reflect specific mutations
associated with the human counterparts, the Lig4Nes-cre and AtrNes-cre mice reflect tissuespecific deletion rather than the hypomorphic mutations reported in LIG4 syndrome and
ATR-Seckel syndrome. Thus each mouse model used carries its own caveats in
translating these data to the respective human conditions. However, it is only through
animal studies that understanding of the neurologic impact of these diseases will ever be
gained, and mice are currently the most accessible mammals in which to undertake
genetic studies.

4.1

Apoptosis Is Central to the Manifestation of Neuropathology
Associated with DSB Repair Deficiencies

The DSB response normally results in either p53-dependant apoptosis or cell
cycle arrest (Vousden & Lu, 2002). The proper balance between cellular death and
proliferation is particularly important to ensure morphological and functional integrity of
the nervous system. Atm-/- mice fail to induce proper p53 signaling in response to either
IR or endogenously occurring DNA damage, resulting in failure of genotoxically stressed
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neural cells to undergo apoptosis (Chong et al., 2000; Gao et al., 2000; Herzog et al.,
1998; Lee et al., 2000; Sekiguchi et al., 2001). This failure to induce p53-dependant
apoptosis is evidence that there is a DSB signaling deficit in the Atm-/- brain, and it is
postulated that cells which would otherwise have been eliminated from the developing
nervous system become incorporated as mature neurons and later undergo degeneration
due to genotoxic stress. It is unknown why mouse models fail to mimic the neurologic
aspects of A-T. It is distinctly possible that there are genetic redundancies in the mouse
brain that are lacking in humans, thus making mice more resistant to Atm loss. Another
theory as to why Atm-/- mice fail to recapitulate the cerebellar ataxia and degeneration
characteristic of A-T is simply that timing of cerebellar maturation and lifespan do not
accommodate the length of time required for such damage to accrue and manifest. It is
typically not until at least 12-14 months of age that ataxia is noted in children with A-T
(Gatti & Swift, 1985). Atm-/- mice typically die of thymic lymphomas between 2-4
months of age (Barlow et al., 1996; Elson et al., 1996), however those that evade tumors
do not exhibit ataxia by 12 months of age. As with Atm-/- mice, Mre11ATLD1/ATLD1 animals
are a phenocopy of the extraneural characteristics of ATLD though there is no direct
evidence of neurodegeneration or consequent ataxia (Theunissen et al., 2003). Because
increased tumorigenesis is not observed in Mre11ATLD1/ATLD1 animals, they survive the
normal murine lifespan up to 2 years, but fail to exhibit signs of neuropathology. Thus,
the shorter lifespan of Atm-/- mice is still an insufficient explanation as to why
neurodegeneration is not observed. Furthermore, the accumulation of "-H2AX and
53BP1 foci without consequent apoptosis in the adult Lig4Nes-cre brain demonstrates that
unlike immature neurons, mature neurons are highly impervious to DNA damageinduced apoptosis. Cell cycle re-entry has been associated with death of post-mitotic
neurons in neurodegenerative disorders such as Alzheimer’s disease and Parkinson’s
disease. It has been suggested that DNA damage promotes cell cycle re-entry of postmitotic Purkinje cells in human A-T tissue samples as well as in Atm-/- and Atm+/- mice
(Yang & Herrup, 2005). In contrast, a separate study claims that Atm suppression
protects post-mitotic cells from cell cycle re-entry and apoptosis in response to DNA
damaging agents (Kruman et al., 2004). Most recently, Cdk5 has been implicated in
activating Atm through phosphorylation of serine 794 in post-mitotic cultured granule
cells. Interruption of Cdk5 signaling reportedly inhibits ATM activation (as indicated by
serine 1981 autophosphorylation and phosphorylation of p53 on serine 18), and prevents
DNA damage-induced cell cycle re-entry in cerebellar granule cells (Tian et al., 2009).
Thus, there is conflicting data regarding whether or not ATM is required to induce
neuronal cell death via cell cycle re-entry or whether ATM deficiency induces death
through such a mechanism in mammalian tissues. Adequate studies of the relationship
between ATM and Cdk5 have not been undertaken in vivo. Furthermore, the indication
that Cdk5 is required for ATM activation indicates the need for further study in regard to
how it and the MRN complex might cooperate in ATM activation, specifically in the
nervous system.
Although the etiology of ataxia in either A-T or ATLD is not clear, both proteins
are required for the DSB-induced death of early post-mitotic neural precursors through
p53 signaling (Chong et al., 2000; Herzog et al., 1998; Lee et al., 2000; Lee et al., 2001;
Sekiguchi et al., 2001; Shull et al., 2009). In contrast, normal p53 signaling and
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subsequent apoptosis at least partially explain the microcephaly observed in LIG4
syndrome and NBS. In the instance of LIG4 syndrome, mouse models provide a very
clear cut case that unrepaired DSBs accumulate in post-mitotic neurons during
embryogenesis and lead to Atm/Mre11/p53-dependent apoptosis that results in a drastic
size reduction of the mature brain (Ferguson et al., 2000; Frank et al., 2000; Lee et al.,
2000; Sekiguchi et al., 2001; Shull et al., 2009). The nuances of Nbs1 function in the
brain are less clear, as despite its interactions with Mre11 and Atm, the impact of
disrupted Nbs1 activity in the nervous system does not overlap with that of either Mre11
or Atm. In the Nbs1!B/!B mutant, a DNA repair defect likely leads to increased cell death
during neurogenesis and subsequent microcephaly. The Nbs1!B allele lacks the
FHA/BRCT N-terminal domains, similar to the mutations identified in NBS individuals
(Williams et al., 2002). According to our data the Nbs1 N-terminus is thus not required
for apoptotic induction through Atm (Shull et al., 2009). This is not entirely surprising as
Atm binds Nbs1 through its C-terminus, and this interaction is required for efficient
phosphorylation of Atm targets (Falck et al., 2005). However, the physiological
significance of this interaction in relation to NBS pathology is complicated. Nbs1!C/!C
mutant mice were indistinguishable from WT in terms of IR sensitivity and chromosomal
stability (Difilippantonio et al., 2007; Stracker et al., 2007). While Stracker et al. reported
defects in the intra-S-phase checkpoint; Difilippantonio et al. did not observe cell cycle
checkpoint defects at any stage. Both groups observed abrogated apoptotic signaling
through Atm in the thymus, but Difilippantonio et al. reported normal apoptotic induction
in the nervous system of Nbs1!C/!C mutants. Thus, the connection between the Nbs1-Atm
interaction and Atm signaling in the brain remains somewhat obscure. The conditionally
null Nbs1 mutant Nbnf6/f6 mice support this conclusion, as p53-dependent apoptosis is a
major contributor to the microcephaly and neurogenesis defects reported in this animal
model (Frappart et al., 2005). Interestingly, NBS and ATR-Seckel syndrome share more
similarities than do NBS and A-T. As already alluded to in Chapter 3, the Nbnf6/f6 (also
on a Nestin-cre background) and AtrNes-cre mice have strikingly similar phenotypes that
feature cerebellar dysgenesis and p53 stabilization. Unlike the AtrNes-cre phenotype
however, p53 deficiency largely corrected the aberrant neurogenesis of Nbnf6/f6 mice,
suggesting that p53-dependant apoptosis was the major factor in microcephaly (Frappart
et al., 2005). Based upon our data and that reported in the Nbnf6/f6, we predict
microcephaly associated with NBS to be the direct result of unrepaired DNA DSBs that
result in p53-dependant apoptosis. Through treatment of neural stem cells isolated from
Nbnf6/f6 pups with the Atm-inhibitor caffeine, Frappart et al. also provided some evidence
that Atm was responsible for p53 induction. However, there is currently no report of
Nbnf6/f6 Atm-/- mice to confirm that to be the case.
While the link to p53 signaling after DNA damage in the phenotypes of Atm-/-,
Mre11
, Nbs1!B/!B, and Lig4-deficient mice is clear, the signaling pathway that
accounts for the AtrNes-cre phenotype remains to be determined. Despite the large amount
of p53-dependant apoptosis observed in proliferating regions of the AtrNes-cre brain, p53
loss did not affect the overall phenotype. This indicates that p53-dependent apoptosis is
only a minor consequence of Atr loss, and that p53 induction is not a major function of
ATR in the nervous system. Though phosphorylation of p53-serine 18 was blocked in the
AtrNes-cre AtmNes-cre animals, total p53 induction was unaffected and apoptosis was not
ATLD1/ATLD1
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dramatically attenuated. These results imply that Atm signaling through p53 was
responsible for the elimination of only a small subset of AtrNes-cre cells, and that Atr and
Atm signaling appear independent though somewhat cooperative in the nervous system.
Indeed, it has been demonstrated using the Xrcc2-/- animals in which p53-dependent
apoptosis occurs in proliferating cells of the developing nervous system that Atm does
not contribute to apoptosis resulting from HR inactivation (Orii et al., 2006). It was
speculated that Atr might be the kinase responsible for stabilizing p53 in proliferating
neural precursors, but that seems less likely to be the case in light of these data.
The half-life of p53 is reportedly only 10-30 minutes and many factors contribute
to activation and stability of the protein (Culmsee & Mattson, 2005; DeLeo et al., 1979).
The major events involved in p53 stabilization include phosphorylation, acetylation,
interaction with MDM2, and proteasome inhibition. Numerous phosphorylation sites
have been identified as contributing to p53 stabilization and activity (Culmsee &
Mattson, 2005). In addition to p53-serine 18, another such site is serine 23 (the human
homologue is p53-serine 20), which has been linked to the apoptotic function of p53.
Studies in mice carrying p53 serine 18/23 to alanine mutations indicate that p53phosphoserine 18 is only partially required for DNA damage induced apoptosis. While
p53S18/23A mutant mice completely rescued neural apoptosis and embryonic lethality in the
Xrcc4-/- genetic background, mice carrying only the S18A mutation barely impacted the
Xrcc4-/- phenotype (Chao et al., 2006). Because the p53S18/23A mutants showed much less
apoptotic induction than either p53S18A or p53S23A mutants, it can be concluded that
phosphorylation of both serine 18 and serine 23 synergistically optimize p53-dependent
apoptosis in proliferating cells (Chao et al., 2003; Chao et al., 2006; MacPherson et al.,
2004). One report indicates that neither ATM nor ATR phosphorylate p53 on serine 20,
which would be consistent with the presence of ATM/ATR-independent, p53-dependent
apoptosis observed in the AtrNes-cre AtmNes-cre mice (Chehab et al., 1999). However, p53serine 23 is a target of Chk2 (Chehab et al., 2000). Chk2 hyperphosphorylation is
severely abrogated in Atm-/- cells (Ahn et al., 2000; Falck et al., 2001; Melchionna et al.,
2000). After IR, the Atm-/- thymus exhibits approximately half the number of viable cells
as does the p53-/- thymus. However, Atm-/- Chk2-/- mice exhibit a similar amount of viable
cells as the p53-/- mice in the irradiated thymus (Stracker et al., 2007). Similarly, IRinduced apoptosis was further abrogated in Mre11ATLD1/ATLD1 Chk2-/- and Nbs1!B/!B Chk2-/thymocytes (Stracker et al., 2008; Stracker & Petrini, 2008). This suggests that Chk2
mediation of p53-induced apoptosis is only partially dependent upon Atm. The level of
p53-phosphoserine 20 has not been examined in the AtrNes-cre mice, but IR-induced
phosphorylation of Chk2 is consistent with levels observed in AtrCtrl embryonic brains
and in cultured neural stem cells (data not shown). Thus, it is necessary to perform
western blot analysis of Chk2 phosphorylation to begin determining the signaling
mechanism behind p53 stabilization in the developing AtrNes-creAtmNes-cre brains.
Though Atr-/Atm-independent Chk2 activity is a highly compelling candidate for
induction of p53 in the AtrNes-creAtmNes-cre nervous system, there are other molecules that
could also be responsible. As already alluded to in Chapter 3, p63 and p73 are also
implicated in IR-induced activation of p53 in the embryonic brain (Flores et al., 2002).
The potential roles of Atr and Atm signaling in mediation of p63/p73-induced p53
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activity have not been explored. ARF signaling is another possible mechanism by which
p53 stabilization might occur in AtrNes-cre AtmNes-cre embryos. The murine Ink4a locus
encodes the tumor suppressor p19Arf, which induces cell cycle arrest through upregulation of p53 expression (Kamijo et al., 1997; Quelle et al., 1995). In Atm-/- MEFs,
p19ARF deficiency reversed premature replicative senescence though Atm-/- ARF-/- mice
retained radiation sensitivity and lymphoma latency was unchanged (Kamijo et al., 1999).
Signaling through p19Arf could thus be responsible for the proliferation defects observed
in the AtrNes-cre nervous system, but if that was the case, then the p53-/- background should
have had a more positive effect upon neurogenesis defects in the AtrNes-cre mice. Indeed,
AtrNes-cre mice were crossed onto an Ink4a/ARF mutant background, with no dramatic
effect upon viability or brain morphology (data not shown). Embryonic studies have not
yet been performed on these double mutants to ascertain the effects of Ink4a/ARF loss on
p53 induction. Regardless of the signaling mechanisms behind p53 induction in the
AtrNes-cre AtmNes-cre mice, it is clear that neither p53-dependent cell cycle arrest nor
apoptosis are significantly responsible for the neurogenesis defects observed in the AtrNescre
mutants. This drastically separates the ATR-Seckel syndrome phenotype from the
phenotypes of A-T, ATLD, NBS, and LIG4 syndrome in which p53 signaling is
paramount.

4.2 The Impact of DNA Damage Signaling upon Cell Cycle
Regulation in Neural Progenitor Cells
While the role of ATM appears to be restricted to post-mitotic cells during
neurogenesis, ATR and MRN are required to ensure replication of neural progenitor cell
populations. The Lig4/Xrcc4 complex is critical to the NHEJ repair pathway, which is the
primary mechanism through which DSBs are repaired in post-mitotic neurons.
Deficiency of either Lig4 or Xrrc4 leads to DNA damage accumulation and Atm/p53dependent apoptosis in post-mitotic cells during neurogenesis (Frank et al., 2000; Gao et
al., 2000; Lee et al., 2000). Xrcc2 is essential for the HR repair pathway, which is
preferred in replicating cells and germline inactivation of Xrcc2 results in embryonic
lethality and neural apoptosis (Deans et al., 2000). In contrast to findings in Lig4deficient mice, Xrcc2-/- animals showed p53-dependent apoptosis in proliferating regions
of the embryonic nervous system that was not Atm-dependent (Orii et al., 2006). This
provided further indication that Atm is primarily involved in initiating apoptosis via p53
in post-mitotic cells during neurogenesis. In unpublished data (not shown) The
Mre11ATLD1/ATLD1 genetic background had no affect upon apoptosis in the embryonic
Xrcc2-/- nervous system, similar to the Atm-/- background (Personal communication with
Dr. Youngsoo Lee, March 6, 2009). However, the Nbs1!B/!B background reduced Xrcc2-/viability from the median age of E13.5 to E9.5, suggesting that Nbs1 has a potential role
in HR (Personal communication with Dr. Youngsoo Lee, March 6, 2009). A role for
Nbs1 function in ensuring replication fidelity through mediation of DNA repair is also
implicated by the Nbnf6/f6; Nestin-cre mutant mouse. In addition to apoptosis,
proliferation was decreased in the cerebellar EGL of these mice, as indicated by BrdU
labeling experiments (Frappart et al., 2005). However, it was not indicated in that report
if this replication defect was related to p53-induced cell cycle checkpoint activation (in
78

other words, was it rescued by p53 deficiency or was it p53-independent, as the
proliferation decrease in the AtrNes-cre mutant seems to be?). Furthermore, the early
embryonic lethality around E7.5 observed in Nbs-/- mice is sufficient to indicate that Nbs1
is required for HR (Zhu et al., 2001).
Similarly, conditional deletion of Mre11 in mouse embryonic stem cells revealed
its requirement for proliferation (Xiao & Weaver, 1997). Mre11 nuclease activity (which
is retained in the Mre11ATLD1/ATLD1 mutant) has recently been implicated in HR repair as
well as in contributing to ATR activation, both of which would be consistent with early
embryonic lethality. Mre11H129N/H129N mutant mice are embryonic lethal by E10.5 due to
overall failure to develop normally, it was particularly noted that there was no evidence
of heart development. Loss of p53 did not impact viability. MEFs derived from a
conditional allele showed decreased proliferation and genomic instability. Though this
mutation did not affect ATM activity, it did confer hypersensitivity to IR and replication
stress, consistent with decreased ATR activity that was indicated by very attenuated
phosphorylation of Chk1 on serine 345 in Mre11H129N/H129N cells (Buis et al., 2008). Thus,
the MRN complex has been linked in vivo to ATR and ATM signaling.
There is evidence that in addition to its interactions with ATM, the MRN complex
is required for maintaining replication fidelity through association with ATR. Nbs1
activity has been implicated both upstream and downstream of ATR signaling. Nbs1 is
phosphorylated on serine 343 by ATR, in response to stalled replication forks (Olson et
al., 2007a). Hyperphosphorylation of RPA in response to hydroxyurea treatment requires
ATR, but phosphorylated Nbs1 is required for this activity independently of ATM
activity (Manthey et al., 2007). It has also been shown that the MRN complex interacts
with ATRIP, a factor required for ATR activation, through the FHA/BRCT domains of
Nbs1 (Olson et al., 2007a). Interaction of the MRN complex with RPA also occurs
through the Mre11 C-terminus and is CDK-dependent (Olson et al., 2007b). Nbs1
reportedly interacts physically with TopBP1, which is involved in ATR activation
through association with ATRIP, and its expression is reportedly decreased in Nbs1deficient cells (Mordes et al., 2008; Morishima et al., 2007). Consistent with
requirements for Nbs1 upstream of ATR signaling, NBS cells reportedly show
diminished phosphorylation of ATR targeted regions on Chk1, c-Jun, and p53 in response
to either UV-irradiation or hydroxyurea treatment (Stiff et al., 2005). Another potential
connection between ATR activity and MRN exists through the CtIP protein. The yeast
homologue to human CtIP is Ctp1, which is required for efficient formation of RPAcoated ssDNA adjacent to DSB sites (Limbo et al., 2007). Human CtIP is recruited to
DSB sites exclusively during S/G1 phases and interacts with the MRN complex. CtIP is
required for DSB end resection and thus for RPA and ATR recruitment to the break site
(Sartori et al., 2007). Though more work is required to firmly establish the relationship
between the MRN complex and ATR, it is a very compelling notion that these molecules
are functionally entwined, particularly in light of their common developmental
requirements and the similar consequences of hypomorphic mutations associated with
NBS and ATR-SS.
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ATR signaling through claspin/Chk1 is critical to both the DNA damage response
and controlling replication (Cimprich & Cortez, 2008). Through Rad17 modulation,
claspin acts as an adaptor molecule at the replication fork to facilitate the ATR-Chk1
interaction, following TopBP1-ATRIP mediated ATR activation (Cimprich & Cortez,
2008; Kumagai & Dunphy, 2000; Liu et al., 2006; Shiotani & Zou, 2009; Wang et al.,
2006). Once activated by ATR, Chk1 is released from chromatin and free to
phosphorylate its own substrates such as the CDC25 phosphatases, which regulate cell
cycle progression (Cimprich & Cortez, 2008; Smits et al., 2006). The human genome
contains 3 CDC25 genes, each of which is subject to alternative splicing. The CDC25
phosphatases regulate cell cycle transitions through dephosphorylating and thereby
activating cyclin dependent kinases (CDKs). All three isoforms (CDC25 A-C) are
involved in regulating the G1-S and G2-M transitions, as well as mitosis. During S-phase,
the inactivation of CDC25A is mediated by DNA damage-induced Chk1 and Chk2
activity. G1 arrest is induced in response to DNA damage when Chk1 phosphorylates
CDC25A, which results in its degradation and subsequent G2 arrest. In response to IR,
Chk1 and Chk2 phosphorylate CDC25C, which prevents its interaction with CDK1cyclin B. CDC25B is also reportedly phosphorylated by Chk1, resulting in G2/M arrest.
In addition to ATM/ATR mediated CDC25 phosphorylation, p38 also regulates
checkpoint activation through CDC25 phosphorylation (Boutros et al., 2006).
The impact of ATR and ATM inactivation upon CDC25 and subsequent cyclin
mediation has not been thoroughly characterized in the nervous system. Cells isolated
from individuals with either ATR-SS or primary microcephaly caused by mutations in the
microcephalin/BRIT1 gene (MCPH1) showed reduced CDC15A degradation associated
with failure to activate the G2/M checkpoint, increased percentage of cells showing
nuclear fragmentation, and an increased number of cells exhibiting supernumerary
mitotic centrosomes in response to DNA damage (Alderton et al., 2006). Chk2 is a major
ATM substrate, and in vitro ATM-deficiency results in G1-S and G2-M checkpoint
failure, as well as early cellular senescence attributed to decreased p53 and Chk2 activity
(Lavin, 2008). In the case of ATR and Nbs1 function in the nervous system, we can
speculate that decreased cell cycle checkpoint activation results in aberrant replication
followed by senescence or apoptosis of cells that have incurred genotoxic levels of DNA
damage, hence the observations of apoptosis and decreased proliferation observed in the
developing brains of AtrNes-cre and Nbnf6/f6 mutant mice (Frappart et al., 2005). Despite the
observations of cell cycle checkpoint defects and early senescence in cells cultured from
ATM deficient humans and mice, as well as from ATLD individuals and the
Mre11ATLD1/ATLD1 mutant animals, the data presented here provides no indication that
either inactivating ATM mutations or the hypomorphic mutations associated with ATLD
have any impact upon cell cycle checkpoint integrity or proliferation in the nervous
system (Lavin, 2008; Stewart et al., 1999; Taylor et al., 2004; Theunissen et al., 2003).

4.3

Concluding Remarks

ATM, ATR, and the MRN complex are integral components of the DNA DSB
signaling machinery. Autosomal recessive genetic mutations in ATM, ATR, Mre11, and
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Nbs1 have been linked to diseases that share many characteristics such as cell cycle
checkpoint deficiencies in cell lines such as fibroblasts, immunodeficiency, increased
radiation sensitivity, and genomic instability. Inactivating, autosomal recessive mutations
in ATM are responsible for ataxia-telangiectasia, which is characterized by
neurodegeneration and consequent ataxia, cancer proneness, ocular telangiectasias,
increased !-fetoprotein levels, and immunodeficiency (OMIM #208900). Hypomorphic
mutations in ATR have been identified in a subset of individuals diagnosed with Seckel
syndrome (OMIM #601215). Seckel syndrome presents with intrauterine growth defects,
microcephaly, dwarfism, and variable degrees of mental retardation (OMIM #210600).
ATR-Seckel syndrome individuals present with these characteristics as well as the above
mentioned hallmarks of genomic instability. ATM and ATR are similar PIKKs that
divide the DNA DSB response between signal transduction of DSBs induced by sources
such as IR and DSBs that result from replication stress, respectively. The MRN complex
is implicated in modulating the activity of both molecules and in directly facilitating DSB
repair through tethering of broken ends and 5’-3’ resection (Cimprich & Cortez, 2008;
McKinnon, 2009). Hypomorphic mutations in its components Mre11 and Nbs1 result in
ataxia-telangiectasia-like disease (OMIM #604391) and Nijmegen breakage syndrome
(OMIM #251260), respectively. ATLD differs from A-T in the absence of telangiectasia
and increased !-fetoprotein levels, but presents with very similar neurodegeneration and
ataxia, but with longer latency. NBS shares many characteristics with ATR-SS,
particularly microcephaly.
This work has sought to delineate the signaling mechanisms that account for the
distinct neuropathology observed in these individual genetic deficiencies using mouse
models. While Atm-/- and Mre11ATLD1/ATLD1 mice show abrogated p53-dependent apoptotic
induction in post-mitotic regions of the developing brain, Nbs1!B/!B animals showed
normal levels of cell death in response to DNA DSBs despite reduced Atm activity. This
data indicates that while reduced elimination of cells harboring DNA damage is involved
in the pathology of A-T and ATLD, the microcephaly associated with NBS is likely
attributable to increased Atm/p53-dependent cell death as a result of DNA repair
deficiency. In terms of Atm signaling in response to DSBs, these results indicate that
there is an as yet undefined threshold of Atm activity required to efficiently induce
apoptosis and that the Nbs1!B/!B mutation does not suppress Atm function to the same
extent that the ATLD mutation does, thus producing different neurologic consequences
when challenged by DNA damage (Shull et al., 2009). By comparing the neuropathology
and neural DNA damage response of AtrNes-cre and AtrNes-cre AtmNes-cre mice, we have
reiterated that Atm is not significantly involved in the DNA damage response of
replicating neural precursors and Atr deficiency results in microcephaly and neurogenesis
defects through a combination of apoptosis and decreased proliferation of neural
precursor cells associated with increased DNA damage in proliferating regions of the
developing brain. While apoptotic signaling proved to be p53-dependent and Atmindependent, the signaling mechanisms behind the proliferation defect in the AtrNes-cre
brain have yet to be identified. Overall, the data presented here provides valuable insights
into the tissue-specific requirements of ATM, ATR, and MRN signaling and sheds new
light onto the etiology of the neurologic phenotypes resulting from deficiency of these
molecules.
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